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Enteroviruses are small, single stranded RNA viruses that are spread via the fecal-oral route and 
encounter the small intestinal epithelium as their primary site of infection. This family of 
pathogens, including poliovirus, coxsackieviruses, and echoviruses, is responsible for pediatric 
and neonatal infections with severe and often fatal outcomes. Echovirus 11 can cause particularly 
devastating neonatal infections, resulting in enteroviral sepsis, meningitis, and hepatic failure. In 
order to gain access to sites where severe virally-induced disease occurs, enteroviruses must first 
overcome the defenses of the epithelial barrier of the small intestine. The human small intestine is 
a complex organ made up of a variety of specialized, differentiated sub-cell types. Research of 
enterovirus infection at this important primary barrier to infection is limited by the fact that no 
accurate in vitro model of infection exists, nor does an animal model that recapitulates the natural 
gastrointestinal (GI) route of infection.  
Here, I utilize two recently developed cell culture models designed to better represent the 
human small intestinal epithelium as it exists in vivo, in order to characterize enterovirus infection 
at this important entry portal. First, I describe the use of a bioreactor and microscaffold beads for 
culturing intestinal cell lines 3-dimensions (3-D). The resulting polarized cell cultures, with 
enhanced brush borders and upregulated expression of intestinal genes, were used to model 
coxsackievirus B (CVB) infection. Secondly, human intestinal enteroid cultures, derived from 
primary intestinal crypts, were used as an ex-vivo cell model. These cells proliferate and 
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differentiate into the repertoire of epithelial cell sub-types found in the human small intestine in-
vivo. Human enteroids were used to study epithelial infection by different enteroviruses. In 
differentiated cultures, we find that the absorptive enterocyte and enteroendocrine cell lineages are 
highly permissive to echovirus 11 infection, while goblet cells were restrictive to infection. 
Contrary to infection in traditional cultures of immortalized intestinal cell lines, we find that 
enteroids derived from the primary intestinal stem cells produce robust antiviral signaling 
following echovirus 11 challenge. In summary, the models for intestinal infection presented in this 
dissertation will allow for novel enterovirus studies not previously possible in undifferentiated cell 
lines. 
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1.0  INTRODUCTION 
Enteroviruses are positive stranded RNA (ssRNA) viruses that belong to the Picornaviridae family. 
These viruses are among the most common infectious agents of humans and are causative agents 
for an array of diverse and debilitating pathologies, affecting a variety of organs and tissue types, 
including flu-like symptoms, paralysis, pancreatitis, hepatitis, aseptic meningitis, myocarditis, and 
dilated cardiomyopathy. The severe diseases caused by enteroviruses are the result of viral 
dissemination to secondary sites of infection. However, viruses such as enterovirus 71, 
coxsackievirus B, echoviruses, and poliovirus are transmitted via the oral route, and encounter the 
small intestinal epithelium as their primary site of infection. Little is known about enterovirus 
infection of the gastrointestinal tract in vivo. No functional animal model exists for intestinal 
infection with these viruses, and cell cultures fail to recapitulate the complex multicellular 
environment and structures of the epithelium, or the diversity of its functions. In recent years, more 
complex and biologically relevant human cell culture models have been developed to study the 
functions of the small intestine by allowing for the differentiation of distinct epithelial cell types, 
and other specialized features of the polarized epithelium. These models will be used to study how 
enteroviruses utilize the epithelium as a primary gateway in order to cause subsequent disease. 
Thus we will be able to discover vital information about enterovirus infection at a site that cannot 
be fully studied by conventional cell culture methodology.  
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1.1 ENTEROVIRUSES 
Members of the Enterovirus are small, 28-30 nm, non-enveloped, positive-stranded viruses that 
belong to the Picornaviridae family. Enteroviruses are responsible for up to 15 million 
symptomatic cases a year, although the majority of infectious are asymptomatic and undiagnosed 
(1). There are over 70 serotypes of human enteroviruses which, together, are responsible for 
illnesses such as flu-like symptoms, gastroenteritis, hand foot and mouth disease, myocarditis, 
dilated cardiomyopathy, pancreatitis, aseptic meningitis, encephalitis, and paralysis (2). 
Polioviruses (PV) and coxsackieviruses A and B (CVA and CVB) were historically 
classified by serotype and disease causation (3). The Enterovirus genus originally contained four 
species, broadly divided by the types of disease the virus causes in mice: CVA, CVB and PV as 
well as enteric cytopathic human orphan viruses (echoviruses), which were originally classified as 
miscellaneous enteroviruses that do not cause disease in mice (4). More recently, enteroviruses 
have been categorized into four species based on molecular and sequence based phylogenetic 
analysis, resulting in four human enteroviruses species (EV-A through EV-D), with distinct 
members numbered based on genetic identity (5, 6). Viruses within these four species are do not 
naturally infect non-human animals, and therefore there is no animal reservoir, though there are 
species EV-J through EV-H containing bovine, porcine, and simian enteroviruses. The EV-A 
species contains Coxsackievirus A 2-8, 10, 12, 14, and numerous other enteroviruses including 
enterovirus A 71 (EV71). EV-B includes CVA9, and many CVB and echoviruses. Among the 
viruses in EV-C are CVA1 and the polioviruses, while EV-D includes EV-D68, which has caused 
respiratory illness and flaccid paralysis in several recent outbreaks (7-9).  
Much of what is known about the molecular biology of enterovirus replication has been 
determined using PV as a model virus. Most enteroviruses spread via the fecal-oral route. After 
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being shed in the gastrointestinal (GI) tract of the previous host, they are transmitted via stool, and 
are introduced orally via contaminated foods or surfaces (10, 11). Enteroviruses bind cell surface 
receptors located on intestinal epithelial cells (IECs) and are subsequently internalized through 
endocytosis, and undergo an uncoating process through which the capsid proteins undergo 
conformational change and the viral genome is ejected from the endosome (12, 13).  
Once the positive-strand ssRNA genome enters the cytoplasm, translation begins. The viral 
genome does not possess a host viral 5’ cap, but rather the virally encoded Vpg protein (14). 
Ribosomes are instead recruited to the genomic stem-loop structure termed the internal ribosomal 
entry site (IRES). The genome encodes a single, long polyprotein. As translation occurs, the viral 
proteases 2Apro and 3Cpro are produced and directly catalyze the cleavage of each independent viral 
protein from the polyprotein, including capsid proteins VP0, VP1, VP2, and VP3 (15). Viral RNA 
(vRNA) is replicated by the RNA dependent RNA polymerase, 3Dpol which binds to a clover leaf 
secondary structure in the viral RNA (16). The resulting negative strand of vRNA serves as a 
template to produce large amounts of genomic RNA that will be packaged into progeny viruses 
that are released through lysis of the host cell membrane, completing the viral life cycle. Many of 
the released virions are shed back into the intestinal lumen and excreted through the stool over the 
course of several weeks. However, more severe pathologies develop when enteroviruses 
disseminate through the host from the GI tract. It is thought that enteroviruses spread from the 
intestine to the lymphatics, and subsequently the blood stream where they induce initial viremia 
before spreading to the various organs where advanced disease develops (11). 
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1.1.1 Poliovirus 
The latter part of the 19th century saw the first major poliomyelitis outbreaks of the modern era 
begin to occur in Western Europe and the Northeastern United States, culminating in dozens to 
over one hundred infections per outbreak (17). By 1907, large-scale epidemics had occurred in 
Sweden and New York City, numbering over one thousand cases, each (17). By the early 1950s, 
poliomyelitis rates in the US had reached an all-time high, with nearly 58,000 reported cases in 
1952 alone (18). Following the release of the Salk vaccine in 1955, poliomyelitis incidence rates 
dropped dramatically, from 13.9 to 0.8 cases per 100,000 individuals (19, 20). In infected 
individuals, acute phase symptoms are only apparent approximately 10% of the time, most 
commonly in children, and consist of only 1-2 days of minor illness including headache, fever, 
and soreness (17). Up to 1% of infections results in CNS-related disease, such as meningitis, limb 
paralysis, or more severe paralysis that can result in respiratory failure. Patients that survive 
poliomyelitis paralysis can recover motor function, though often with pain and atrophy of the 
previously afflicted muscles, a condition termed postpoliomyelitis syndrome (21).  
Enterovirus research, and indeed the field of mammalian virology research, began with the 
identification of PV as a “filterable agent” recovered from a child with advanced poliomyelitis in 
1908 (22). While bacteria were removed through filtration, the filtrate was found to produce 
transmissible poliomyelitis paralysis in monkeys, observed as leg paralysis and lesions in the brain 
and spinal cord (23, 24). In 1909, it was further demonstrated that the infectious agent could be 
successively passed between infected animals and neutralized by the serum of previously infected 
humans (25). Much of the fundamental virology of the enterovirus life cycle, as described here, 
was first discovered through the study of PV. Early PV research investigated the hypothesis that 
infection occurred via the mucosal surface of the nasopharynx (26). It was shown by one group, 
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as early as 1912, that there is also evidence of PV infection in the small intestine, in addition to 
the upper respiratory tract, however they did not suggest the GI tract as a route of primary infection 
and this remained largely overlooked for many years (26). It was later shown that PV could infect 
rhesus and cynomolgus macaques after being delivered orally. This finding and the recovery of 
infectious PV from poliomyelitis patient stools in 1939 supported the hypothesis that PV infects 
humans via the intestinal tract (27).  
As enteroviruses passes through the GI tract, they encounter the small intestinal epithelium 
as a barrier to infection (28, 29). Following infection of epithelial cells, this breached barrier 
becomes infected and serves as the enterovirus’s portal to the body, allowing it access to secondary 
sites after the development of primary viremia. Interestingly, most enteroviruses are not known to 
cause pathology within the small intestine itself, but rather in the tissues the viruses reach following 
dissemination. PV that has overcome the epithelium infects Peyer’s patches, from which it spreads 
to other lymphoid tissues (17). In cases of severe disease, disseminated PV reaches the central 
nervous system (CNS) where it infects spinal cord and other motor neurons. 
 Poliovirus research also included the earliest virology studies performed in in vitro human 
cell cultures. It had been expected that PV was capable of replication in non-neuronal cells, based 
on the aforementioned studies describing a GI entry route, and the ease of transmission of the virus 
between humans. Enders et al. showed that PV could be produced by and continually passaged in 
cell cultures derived from fetal brain, intestine, and skin epithelial cells (30). The ability to produce 
large amounts of enteroviruses in culture accelerated research in the field, allowing for more 
studies to be performed from isolates collected from a single patient. In addition to allowing for 
the eventual development of polio vaccines, the ability to screen for enteroviruses based on the 
cytopathic effect (CPE) observed in cell cultures led to the identification of many other members 
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of the genus including echoviruses and coxsackieviruses (23). It also allowed for in depth studies 
on enterovirus pathogenesis and the viral life cycle.  
1.1.2 Coxsackieviruses 
In the process of studying PV, viral particles were isolated from stool samples that came from 
children presenting symptoms of poliomyelitis, as described above. In 1947, in Coxsackie, New 
York, filtrates containing similar but serologically distinct viruses were discovered to cause 
infection in mice. These non-polio enteroviruses were named coxsackieviruses (31) and subtypes 
were divided into two groups based on the pathologies they produce in mice. Group A 
coxsackieviruses (CVA) infect the skeletal and muscle tissue, and cause flaccid paralysis in mice. 
Group B coxsackieviruses (CVB), which were discovered shortly thereafter, also through 
screening of patients’ stools, infect the murine central nervous system, causing tremors and spastic 
paralysis (32). These viruses also infect a wide variety of other tissues, and cause disease of the 
heart and pancreas. Further subtypes were classified by serological and, later, genetic distinction 
(33). 
The majority of coxsackievirus infections in humans are asymptomatic (34). However, in 
a minority of cases these viruses can result in clinical symptoms. Coxsackie infection occurs most 
commonly in the late Summer and early Fall in temperate regions (35). CVB symptoms most 
commonly include febrile illness including fever, headache, conjunctivitis, and irritability 
beginning approximately 3 days following infection and generally subsiding within a week (11). 
Severe infections, which are most common in infants and neonates, can lead to disease in the heart, 
CNS, and pancreas. Serological and RNA PCR studies have shown high rates of patients with 
myocarditis and dilated cardiomyopathy are positive for CVB (as high as 50% and 41%, 
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respectively) (36, 37). CVB is also a leading cause of aseptic meningitis in the US and other 
countries that vaccinate against the mumps virus (1). Coxsackieviruses of group A are responsible 
for peripheral manifestations including hand foot and mouth disease and herpangina. Symptoms 
usually abate within a 7-10 days, although  in rare instances, neurological complications can arise 
as well (38). 
1.1.3 Enterovirus 71 
EV71 is a relatively new virus that is most closely related to CVA16, which it is thought to have 
shared a common ancestor as recently as 1941 (39), based on VP1 sequence. As with CVB and 
PV, EV71 infection establishes itself first through the intestine, though this does not typically 
result in more than mild GI symptoms. In contrast, disseminated EV71 can cause hand foot and 
mouth disease, consisting of painful ulcers and a fever, or potentially fatal neurological disease 
including encephalitis, aseptic meningitis, and CNS-related pulmonary failure (40). EV71 was first 
isolated in 1969 from the stool of a child with encephalitis and, subsequently, from 20 other 
patients with CNS illness over the next four years (41).  
Since then, there have been multiple major outbreaks, mostly in the Asia-Pacific region. A 
1998 outbreak in Taiwan resulted in thousands of cases of hand foot and mouth disease, and caused 
the deaths of 78 people (42), with the primary cause of death being brainstem encephalitis (40, 
43). In 2008, an outbreak occurred in Fuyang city in South China, resulting in the hospitalization 
of over 6,000 people in several months (43). Interestingly, the main virus recovered from patient 
isolates in this outbreak appears to be a recombinant EV71 strain containing the CVA16 (strain 
G10) 3Dpol sequence that encodes the viral RNA-dependent RNA polymerase (43). In 2012, EV71 
was responsible for the deaths of 54 children in Cambodia (44). 
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1.1.4 Echoviruses 
Echoviruses, like coxsackieviruses, were discovered as a direct result of enterovirus cell culturing 
that was first performed with poliovirus (4). The ability to neutralize virus with antibody led to the 
descriptions of more than 34 echovirus serotypes (45), although several have since been 
reclassified based on genetic analysis. As with CVB, echovirus infections with clinical 
manifestations are most frequently reported as febrile illnesses as well as rashes, with less common 
symptoms affecting the CNS. Although there have been numerous reports on the epidemiological 
aspects of echoviruses, the field is relatively lacking in data surrounding their molecular biology. 
In vitro, some echoviruses (5, 9, and 11) are capable of replicating in human blood mononuclear 
cells, while CVB3 and CVB4 are unable to do so (46), suggesting that pathogenesis could vary 
greatly among members of the EV-B species. It is known that echovirus 1 (E1) and E8 use very 
late antigen-2 (VLA-2) α2 subunit as a receptor (47, 48), but the primary receptors for many 
echoviruses remain unknown. For several echoviruses, including E6, E7, E11, E12, E20 and E21, 
efficient binding of virions to cell surfaces is dependent on decay accelerating factor (DAF or 
CD55) (49). However, low binding affinity and the fact that CVB uses DAF as a non-essential co-
receptor suggest that it may not be the primary receptor for these echoviruses (50).  
1.1.5 Neonatal enterovirus infection 
Although the majority of enterovirus infections in adults are asymptomatic, these viruses present 
a significant threat to young children and neonates. As reviewed in (51), neonatal enterovirus 
infection was first studied during the poliomyelitis epidemic (52). In one report, approximately 
40% of cases analyzed where mothers had poliomyelitis, infants were found to be positive for the 
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virus within the first month of life, potentially having become infected by contact with maternal 
blood during birth, or through other contact with the mother shortly after (52). Less commonly, 
the virus can be transmitted to developing fetuses in utero, as newborns have displayed symptoms 
of polio several days after birth (53). However, even in the absence of direct viral transmission, 
the effects of PV infection on a pregnant woman can be devastating for the fetus, and can result in 
fetal wasting or premature delivery (54). Despite this, relatively few PV infections overall occur 
via vertical transmission compared to the number of pediatric cases that result from infections 
occurring later in childhood (52). 
 As with PV, CVB infection in pregnant women can have severe outcomes. The frequency 
of infection during pregnancy is not known precisely as many CVB infections in both children and 
adults are asymptomatic and CVB is not routinely screened for (51). One epidemiological study 
found that 75% of infants that were serologically positive for CVB viruses were asymptomatic 
(45). Others have reported that 42% of pregnant women surveyed were seropositive for an 
enterovirus (55), and that 9% of pregnant women were positive for coxsackievirus B (56). CVB4 
has been reported to have an extremely high neonatal case fatality rate of up to 40% (57). In 2007, 
a CVB1 outbreak in newborns in the United States caused severe myocarditis and resulted in five 
deaths (58). All of the infected neonates observed by Verma et al. showed signs of illness within 
two weeks of birth and 60% of mothers were ill, leading them to hypothesize that the virus may 
have spread across the placental barrier. Multiple nosocomial outbreaks of CVB have also been 
reported, resulting in myocarditis, encephalitis, and meningitis (59-61).   
Echovirus infections are often acquired through nosocomial means and can also cause 
severe pathologies in neonates. In particular, neonates may be at greater risk to nosocomial E11 
infection (62). Infants that were born prematurely or with a low birth weight are especially 
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susceptible to echovirus disease (55, 63). Neonates are prone to the most severe and often fatal 
manifestations of enteroviral infections including meningoencephalitis, myocarditis, and hepatitis 
(62). Nosocomial enterovirus infections within neonatal intensive care units, the most frequent of 
which are E11 and CVB infections, can account for between 15-30% of total neonatal intensive 
care unit (NICU) associated nosocomial viral infections are associated with significant morbidity 
and mortality (64-67). The National Enterovirus Surveillance System (NESS) has reported 
neonatal case fatality rates for E11 to be as high as 19% over a 20-year period (1983-2003), with 
E11 as the most frequently reported non-poliovirus enterovirus detected over the same period (57).  
1.2 THE HUMAN SMALL INTESTINE 
The intestines are complex organs that comprise the largest mucosal surface in the body. The small 
intestine performs the critical role of absorbing nutrients and minerals from food, while serving as 
a barrier to pathogens and other harmful products. The small intestine is made up of a long tube of 
several separate tissue types, as reviewed in (68). The innermost layer is the mucosa. This tissue 
is covered by a lumen-facing epithelial monolayer that is constantly renewed, and is folded into 
complex villus projections and crypt structures containing various polarized cell types, each of 
which possesses specialized functions in order to mediate the absorption of nutrients, deliver 
antigen to immune cells, and provide a barrier to infectious agents. Underlying the epithelium is 
the lamina propria, containing myofibroblasts, nerve fibers and immune cells. The outermost tissue 
is composed of several circular sheets of smooth muscle that produce the peristalsis responsible 
for motility of food within the lumen. The epithelium and smooth muscle layers are connected by 
the submucosa, which contains vasculature, lymphatics, and connective tissue.  The small intestine 
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is divided into three regions. The duodenum is the proximal end of the small intestine. After 
leaving the stomach, food enters the duodenum where it is combined with bile salts and enzymes 
from the pancreas and liver that aid in digestion, which subsequently occurs in the jejunum, and 
ileum, along with nutrient absorption. Finally, the luminal contents are passed to the colon for 
resorption of bile salts and water. The following section describes the development and features 
of the small intestine. 
1.2.1 Development of the small intestine 
Following gastrulation, human embryos are comprised of three specialized germ layers. By the 
end of organogenesis, the ectoderm layer forms the epidermis and central nervous system, while 
the mesoderm forms many tissues including the endothelium and other circulatory components, 
connective tissue, bone, cartilage, and muscle. The endoderm gives rise to the organs involved in 
the circulatory and digestive tracts, including the small and large intestines, liver, pancreas, and 
lungs. Early in gastrulation, exposure to the growth factor Nodal results in high expression levels 
of growth factors such as Cdx2 and Hhex which determine the anterior and posterior endoderm 
regions, the latter of which eventually develops into the intestinal tract (69). As the endoderm 
grows, in a process termed tubulogenesis, it folds into a tubular shape, develops portals on the 
anterior and posterior, and forms connections to the mesoderm. This early tube formation extends 
and layers the epithelium begins the process of polarization, as cells exposed to the lumen form 
tight junction (TJ) complexes. In mammals, increases in fetal intestinal girth and the early 
formation of villus structures is thought to occur via pseudostratification (70). These columnar 
epithelial cells, with nuclei associated with their basement membranes, become further elongated 
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along their axis. In contrast, the esophagus, which is also endoderm-derived, is made up of properly 
stratified, independent basolateral and luminal cell layers (71). 
1.2.2 Cell differentiation and function 
Mesenchymal interaction with the intestinal epithelium, by physical means and through signaling 
mechanisms, is critical for the formation of the villus and crypt structures of the small intestine 
(72). Platelet derived growth factor (PDGF) and Hedgehog ligands are produced by IECs and 
signal to the mesenchyme through their receptors, PDGFR and Patched, respectively, to induce 
differentiation of mesenchymal stem cells into myofibroblasts (73-75). Mesenchymal cells, in turn, 
produce Wnt3a and bone morphogenic protein (BMP) to initiate epithelial differentiation through 
the Wnt/β-catenin signaling pathway. Intestinal stem cells (ISCs) are located at the base of 
invaginations between villi, termed crypts of Lieberkuhn (as shown in Figure 1). These actively 
dividing ISCs are called crypt base columnar stem cells (CBCs) and are typified by the expression 
of Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) and olfactomedin 4 
(OLFM4) (76-78). Wnt and BMP signaling is critical for crypt development as it results in Lgr5+ 
ISCs irreversibly differentiating into Paneth cells, which migrate downwards from ISCs into the 
crypt base (79). CBC stem cell maintenance is dependent on Wnt signals that are further amplified 
by the R-spondin proteins, Rspo1-4 (80). Quiescent stem cells that are Lgr5-, Tert+ (telomerase 
reverse transcriptase) and unresponsive to Wnt and BMP signaling (81) are located at what is 
termed the +4 position (i.e., they are 4 cells away from the base of the crypt). These slowly dividing 
stem cells are not currently well understood but, in mice, it is thought that they are responsible for 
replenishing the full array of differentiated IECs after intestinal injury, via differentiating first into 
Lgr5+ ISCs (82). 
 13 
Intestinal crypts are composed entirely of CBCs and Paneth cells, but the majority of cells 
that arise as a result of asymmetric differentiation of CBCs are transit amplifying cells (TA). TA 
rapidly undergo 4-6 cell divisions, expanding outwards from the crypt before irreversibly 
differentiating into the mature cell types that make up the villi (79). Epithelial cells proliferate and 
migrate up towards the tips of villi, where they are extruded. This process of cell shedding leads 
to a rapid, regular turnover of entire villi every 2-6 days, making the intestinal epithelium the most 
frequently replaced tissue in the body (83). After migrating beyond boundaries of crypts, TA 
undergo differentiation, first producing short-lived multipotent progenitors (84) that are not well 
understood, before terminally differentiating into absorptive and secretory cell lineages.  
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Figure 1. The intestinal epithelium is comprised of villi and crypts of Lieberkühn. Columnar base stem cells (CBCs) 
localized within crypts give rise to the diverse array of epithelial cells. Cells at the +4 position (from the crypt base) 
are quiescent in normal conditions, and are thought to differentiate following tissue damage in order to rapidly replace 
other cell populations. Within the crypt, CBCs differentiate into anti-microbial Paneth cells. CBCs also differentiate 
into transit amplifying cells, which travel upwards, away from the crypt base before undergoing terminal 
differentiation into cells that make up the villi. Absorptive enterocytes are responsible for nutrient uptake, and are the 
most prevalent cell type in intestinal villi. Other cells include those of secretory lineages, such as mucus-secreting 
goblet cells and enteroendocrine cells, which release hormones to regulate intestinal function. 
 
In addition to supporting CBC renewal, Wnt3a ligand also contributes to the differentiation 
of Paneth cells which, instead of migrating towards the villus tips, travel further into the crypt base 
(85). Paneth cells, in turn, produce transmembrane type I ligands including Delta-like 1 and 4 (Dll1 
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and Dll4) (86). These molecules bind Notch receptors on adjacent CBCs, resulting in the cleavage 
and release of Notch intracellular domain (NICD) in a disintegrin and metalloprotease (ADAM) 
and γ-secretase dependent manner (87-89). NICD translocates to the nucleus, where it induces 
transcription of Hairy and enhancer of split 1 (Hes1) to promote the differentiation of absorptive 
cells, enterocytes. Hes1 is also a repressor of Atonal homolog 1 (Atoh1, also known as Math1) 
(90), which is an essential gene for the initiation of secretory cell lineage differentiation (91). Mice 
lacking Atoh1 have intestinal epithelia that are mostly devoid of secretory cell types, instead 
containing nearly entirely enterocytes (92). The balance of Wnt and Notch signaling, and thus 
Hes1 and Atoh1 expression, provide homeostasis of stem cells, enterocytes, and secretory cells in 
the intestine (68, 93, 94).  
Cells of the secretory fate can be further classified under several sub-lineages, depending 
on their exact pathways of differentiation. Expression of Neurog3 is sufficient to produce 
terminally differentiated, hormone secreting enteroendocrine cells. Alternatively, expression of 
growth factor independence-1 (Gfi1) can drive cells instead towards a Paneth or goblet cell fate 
rather than enteroendocrine (95). Terminal differentiation of goblet cells is dependent on 
expression of the transcription factor Krüppel-like Factor 4 (Klf4) (96, 97) while Paneth cells 
require SRY-box 9 (Sox9) (98, 99). Tuft cells, a fourth type of secretory lineage, have also recently 
been defined (100), although the process by which these cells differentiate has not yet been 
described aside from the fact that it is Atoh1-dependent (101). Unlike secretory cell types, 
Microfold cells (M cells) do not differentiate in crypts of Lieberkühn, but in Peyer’s patches, as a 
result of signals from underlying lymphoid cells (102). The released receptor activator of nuclear 
factor kappa-B ligand (RANKL) by these cells binds RANK on recipient precursor M cells (102), 
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inducing expression of transcription factor SPIB that is sufficient and required for M cell 
development (103). The following sections further review the properties of epithelial sub-lineages. 
1.2.2.1 Absorptive cells. Enterocytes are the most numerous of the various epithelial sub-types 
and comprise the bulk of intestinal villi. These cells are responsible for the absorption of molecules 
from the intestinal lumen including water, polysaccharides, lipids, vitamins, and peptides. The area 
of the apical surfaces of enterocytes is dramatically increased by the structure of the brush border. 
This luminal surface is comprised of thousands of actin-based projections called microvilli, 
increasing absorption as well as the presence of digestive enzymes in the lumen. Enterocytes 
transport immunoglobulin A from their basolateral surface to the lumen, and may play roles in oral 
tolerance, immunomodulation, and regulation of intestinal cytokine levels (104). 
1.2.2.2 Secretory lineages. Secretory cells are present throughout the epithelium, though in lesser 
abundance compared to absorptive cells. There are four known secretory sub-lineages: goblet, 
enteroendocrine, tuft, and Paneth cells. Unlike the other types, Paneth cells are located directly 
adjacent to stem cells within crypts. Paneth cells are responsible for the production of antimicrobial 
compounds, including alpha defensins (DefA), cryptidins, and lysozyme, which are packaged into 
cytoplasmic granules. Upon detection of microbial pathogens, granules are secreted into the 
intestinal lumen. As described in the previous section, Paneth cells also contribute to Wnt/β-
catenin signaling to CBCs within crypts. 
 Goblet cells are located in villi, intermixed with absorptive cells and secret mucus in the 
form of high molecular weight glycoproteins. Together, these mucins produce the glycocalyx, 
which covers the microvilli in order to protect the epithelium from harmful compounds and 
pathogens, while still allowing smaller molecular weight particles, such as nutrients, to reach the 
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epithelial surface (105). Expression of mucin-2 (MUC2) is a widely accepted marker for goblet 
cells. 
 Enteroendocrine cells are responsible for secreting hormones into the intestinal lumen. 
There are at least 16 different enteroendocrine sub-lineages that are known. Chromogranin (Chga) 
is a general marker for enteroendocrine cells, and is present within cytoplasmic vesicles, along 
with other compounds including serotonin, somatostatin, oxyntomodulin, and glicentin (106). 
These vesicles are released into the lumen following depolarization of the plasma membrane (107) 
to regulate many GI processes including gastric motility, peristalsis, gastric secretion, appetite, 
and enterocyte proliferation (106). 
 Tuft cells are the most uncommon epithelial sub-lineage in the intestine, and are 
correspondingly poorly understood. Tuft cells may be capable of detecting molecules, such as 
nutrients, in the intestinal lumen, as they express proteins that are related to those responsible for 
taste sensation. Additionally, tuft cells synthesize endogenous opioids such as β-endorphin, and 
secrete them into the lumen (108), which may control intestinal processes such as motility, in 
addition to providing analgesic effects. Tuft cells have a unique morphology, which is 
characterized by a small bundle of microfilaments on the apical surface (109). There are few cell 
markers specific for human tuft cells. This, along with their low abundance makes identification 
of tuft cells difficult. However, doublecortin and calcium/calmodulin-dependent protein kinase-
like-1 (DCLK1) has been identified as a murine tuft cell marker, having been previously 
misattributed to quiescent +4 ISCs (110) as both linages are long-lived (at least 18 months (111)) 
compared to enterocytes and goblet cells that are turned over rapidly. Long-lived tuft cells have 
also been implicated in giving rise to colorectal cancer in a murine model (111). 
 18 
1.2.2.3 Microfold cells. M cells do not share the same lineages as the previously described cell 
types. They are located primarily within follicle-associated epithelium that overlies areas of 
lymphoid cells in the gut-associated lymphoid tissue (GALT). By microscopy, M cells are 
discernable from neighboring enterocytes due to the absence of a thick brush border and by the 
expression of glycoprotein 2 (GP2) (112). M cells sample macromolecules from the intestinal 
lumen, and, through the uptake of immunoglobulin A (IgA), to deliver the antigen to underlying 
lymphoid cells for immunosurveillance (113).  
1.2.3 Infection of the intestinal epithelium 
To date, the roles of specific epithelial sub-lineages in restricting or otherwise affecting enterovirus 
infection are poorly characterized. It is also not known if enteroviruses target specific cell types, 
or if tropism varies between lineages. Some of the first studies on this front have concerned PV, 
which adheres to the surfaces of M cells (114), although it was not known at that point if PV 
actually established infection of these cells. Years later, it was discovered that, in a differentiated 
Caco-2 model containing “M like cells”, PV undergoes transcytosis from the apical surface of 
these cells to the basolateral, with fairly low efficiency (115). It remains to be seen if this process 
occurs in vivo, if M cells can be directly infected by PV, and whether transcytosis through M cells 
is the primary mechanism by which PV bypasses the intestinal barrier in order to infect the 
underlying tissue or disseminate to other parts of the body such as the central nervous system.  
PV is not the only pathogen to take advantage of M cell antigen uptake to bypass the 
intestinal barrier. Both murine norovirus and reovirus utilize M cell transcytosis to reach their 
target cells (dendritic cells and enterocytes, respectively), and reovirus infection is entirely 
dependent on M cell function (116). Salmonella enterica serovar Typhimurium not only undergoes 
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transcytosis to surpass the epithelium, but also induces IECs to differentiate into M cells in order 
to do so with greater efficiency (117). M cell transcytosis also acts as a gateway for ingested prions, 
infectious proteins that are the causative agents of spongiform encephalopathy, to enter the body 
(118). Mice lacking M cells due to RANK knockout were protected from disease by prions 
delivered orally (118). 
Enterocytes comprise the majority of the intestinal barrier, which protects us from invasion 
by enteric pathogens. Rotavirus can impair the epithelial brush border, leading to diarrhea, as the 
virus specifically targets enterocytes near villus tips for infection (119, 120). As described in 
section 1.1.2, coxsackievirus enters intestinal cells not directly through the apical surface, which 
is covered in a dense network of microvilli, but by inducing cytoskeletal rearrangements that 
provide access to the tight junction, where viral receptor CAR is located. The protective ability of 
this barrier can be compromised during periods of inflammation. It has been shown that, following 
inflammation, wound healing quickly occurs to repair tight junctions and reduce intestinal 
permeability, in a process that requires STAT5 to induce the expression of TJ protein zonula 
occludens (ZO) (121). Enterocytes also express the bactericidal compound (Reg3γ) (122)and may 
play a direct role in controlling bacterial infection as well. 
Paneth cells are critical for defense against bacterial pathogens. Paneth cells secrete 
granules containing bactericidal compounds such as lysozyme, Reg3a, and the cationic peptide 
DefA5. Additionally, released DefA6 can form fibrils which immobilize bacteria (123). Paneth 
cells are not stimulated by luminal commensal bacteria, but they can directly detect invasive 
pathogens through MyD88 activation, which triggers granule release (124). Although Paneth cells 
are always described as providing an antibacterial response as their primary function, they have 
recently been found to play a role following SIV infection in rhesus macaques, which causes the 
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expansion of Paneth cells (125). The destruction of neighboring epithelial cells triggers the release 
of interleukin-1 beta (IL-1β) from Paneth cells, resulting in inflammation during very early stages 
of infection (126). 
Goblet cells contribute to the intestinal barrier primarily by producing the mucin-rich 
glycocalyx layer. MUC2 is adept at neutralizing rotavirus infectivity, and production of MUC2 by 
goblet cells has been observed to increase upon infection with rotavirus in mice (127). Increased 
mucin production can be stimulated by the presence of toxins (128), bacterial invasion (129), or 
by commensal bacteria in order to prevent the adherence of pathogens (130). 
Little is known about tuft cells, including the role they may play in defense against viral 
and bacterial pathogens. However, tuft cells are involved in the expulsion of helminth parasites. 
Following infection, tuft cells produce IL4 and IL25, thereby activating type 2 innate lymphoid 
cells and inducing goblet cell mucin production in order to expel the helminth (131, 132). IL13 
production by innate lymphoid cells then promotes the differentiation of additional goblet and tuft 
cells within crypts (133). IL25 expression is also important for defense against cytotoxicity in 
Clostridium difficile induced colitis (134), and reduced IL25 is found in patients with Crohn’s 
disease and ulcerative colitis (135), leading some to hypothesize that tuft cells play an important 
role in controlling bowel inflammation (136).  
1.3 MODELS FOR STUDYING ENTEROVIRUS INFECTION 
In vitro cell culture has been invaluable in understanding many aspects of enterovirus infection. 
Historically, the advancement of cell culture technology has been tied to enterovirus research. In 
the 1930’s, work was underway to develop a vaccine to bring an end to the poliomyelitis epidemic. 
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Unlike bacterial pathogens, which at the time could be isolated and plated in vitro, viruses are 
unable to grow without a host cell. As a result, viral vaccines had to be passaged in animals. In 
early attempts at producing polio vaccines, researchers grew the virus in monkey spinal cords 
(137). Virus produced from these monkey models was inactivated and used in vaccine trials. In 
1935, a trial with incompletely inactivated virus resulted in the paralysis of many children, and the 
delay of further polio immunization research (138). Albert Sabin’s group found that PV infects 
embryonic neural tissue cultures and, in 1949, John Ender’s laboratory successfully produced cell 
cultures of skin and muscle tissue in which PV could be productively cultured (30, 139). In 1951, 
Salk’s laboratory established a method to grow large volumes of high tittered PV stock in monkey 
kidney cultures, allowing for the mass production of inactivated PV vaccines (140, 141). These 
techniques, and the repeated passaging of PV in vitro also led to the development of the live 
attenuated Sabin poliomyelitis vaccines. In vitro cultures also allowed for the identification and 
isolation of other members of the enterovirus family including coxsackieviruses and echoviruses. 
Since those early days, an enormous amount of progress has been made in cell culturing. Cell lines 
have been established for countless species and tissue types, including polarized cell types such as 
those in the intestinal epithelium. 
1.3.1 Enterovirus infection in polarized cell lines 
Polarized epithelial cells form the surfaces that are in direct contact with the exterior environment. 
To mitigate interactions between underlying tissue and the outside world, polarized cells feature 
distinct properties within their apical and cytoplasmic domains. Intestinal epithelial cells have a 
lumen-facing apical domain that is covered in a dense network of actin-based microvilli. This 
surface, termed the brush border, serves in a protective capacity in addition to substantially 
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increasing the apical surface area. This allows for the efficient uptake of nutrients through channels 
and transporters on the cell surface and better availability of digestive enzymes. The basolateral 
surface also contains molecular transporters, and binds cells to the underlying basement 
membrane. Between cells, tight junction protein complexes form a strong seal, protecting the 
underlying mesenchyme from direct exposure to elements in the lumen including pathogens. Some 
cell lines have been used to model epithelial barriers, as they become polarized under certain 
culturing conditions, which can be observed and measured as transepithelial electrical resistance 
(142). Early work on viral infection of polarized cells showed that respiratory viruses can infect 
via the apical surface depending on accessibility to viral receptors (143). Human colorectal 
carcinoma cells, Caco-2, have been widely utilized as a model of enterocytes due to their ability 
to become polarized in culture, resulting in brush border structures and metabolic enzymes, as well 
as the development of tight junctions and high transepithelial resistance (144, 145). 
Enterovirus infection of polarized IECs differs from non-polarized cell types, such as HeLa 
cells, in several interesting ways. It was discovered that, in intestinal and respiratory epithelial 
cells, localization of the coxsackievirus receptor, CAR, is restricted to the tight junctions, while in 
non-polarized cells CAR is localized throughout the plasma membrane (146). As a result, more 
focus was placed on the specific mechanisms by which CVB infects the polarized epithelium. CVB 
entry into polarized cells first requires the binding of viral co-receptor, DAF, a 
glycophosphatidylinositol (GPI)-anchored protein located on the cell’s apical surface. DAF 
binding induces actin-dependent cytoskeletal rearrangements that allow the virus to access TJ-
localized CAR (147). After the virus binds CAR, it enters the cell via caveolin-mediated 
endocytosis (148). Polarized cell culture has also been used to demonstrate that E11 can similarly 
 23 
utilize DAF to gain entry to polarized cells, though a primary receptor has not yet been identified 
(49, 149, 150).  
Other stages of the viral life cycle are affected by cell polarity, including viral release. As 
a lytic virus, CVB requires the destruction of host cells in order to facilitate its release and 
dissemination. This was first demonstrated in non-polarized HeLa cells, in which CVB causes the 
induction of host cell death via apoptosis (151). The apoptotic pathway is highly regulated and 
results in the organized degradation of organelles, chromosomes, and membranes. The cellular 
remnants are compartmentalized into non-immunogenic membranous “blebs” for engulfment by 
phagocytic cells (152). However, our lab has shown that in polarized IECs, CVB infection does 
not induce apoptosis and instead results in the induction of an alternative form of regulated cell 
death, termed necrosis or necroptosis (153).  
Necrotic cell death is characterized by swelling of the cell and its organelles, dysregulation 
of mitochondrial fission, and nuclear and plasma membrane permeabilization and the release of 
cell contents into extracellular space. The release of inflammatory cytokines and damage 
associated molecular patterns (DAMPs) can recruit immune cells to the site of lysis as well as 
activate innate immune signaling (154). Our laboratory has published that CVB infection in 
polarized Caco-2 cells, but not non-polarized HeLa cells, induces necrotic cell death via the 
activation of calpain proteases caused by the release of endoplasmic reticulum-derived Ca2+ stores 
(153). These calpains cleave tight junction proteins such as occludin, impairing the structural 
integrity of the cell and resulting in cell death. Although necrosis was previously believed to be an 
uncontrolled event, whereby the cell membrane bursts due to swelling or physical damage, it is 
now known that this form of death is tightly regulated. Abrogation of necrotic signaling at the 
stage of ER calcium release negatively impacts viral egress without affecting titers of intracellular 
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virus (153). Analogous CVB cell death studies in non-polarized cells have demonstrated that 
inhibition of apoptosis impedes viral release as well (155).  
Additionally, we have found that these intestinal lines, but not cell types that die 
apoptotically from CVB, express receptor interacting protein kinase 3 (RIP3), which has been 
described as a molecular switch that can cause a signaling cascade resulting in necroptotic, rather 
than apoptotic, cell death (156, 157). Our lab revealed, through a genome-wide RNA-interference 
screen, that RIP3 is also required for efficient CVB replication in polarized epithelial cells. 
Surprisingly, RIP3’s role in CVB replication was discovered to be associated with a novel function 
whereby RIP3 regulates autophagy (158), a cellular process in which organelles and other cellular 
components are recycled. In periods of cell starvation, autophagy is used to maintain cellular 
metabolism. CVB has previously been shown to use host membranes in order to concentrate 
components required of viral replication (159) via the induction of a non-canonical autophagy 
pathway (160). Furthermore, our group discovered that CVB directly affects RIP3 activity by 
means of the virally encoded protease, 3Cpro (158).  
Previous to our group’s finding that CVB 3Cpro cleaves RIP3, we have previously 
published that, in polarized epithelial cells, 3Cpro antagonizes innate immune signaling in order to 
benefit its own replication (161). The recognition of pathogens by the innate immune system relies 
on the detection of pathogen associated molecular patterns (PAMPs) by cellular pattern 
recognition receptors (PRRs). This task is performed by different classes of receptors, including 
Toll-like receptors (TLRs) and retinoic-acid inducible gene (RIG) like receptors (RLRs). RNA 
viruses can be detected by RNA-binding PRRs including TLR3 in endosomes, as well as cytosolic 
receptors, RIG-I and melanoma differentiation-associated protein 5 (MDA5). After binding the 
viral PAMP, these receptors signal through several adapter proteins required to stimulate interferon 
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(IFN) and nuclear factor κ light chain enhancer of B cells (NF-κB) production in order to establish 
an antiviral, inflammatory state (162). 
CVB 3Cpro cleaves signaling proteins including Toll/IL-1 receptor domain containing 
adapter inducing IFNβ (TRIF) (163). TRIF is a critical adapter molecule that relays a signal from 
TLR3 and the lack of functional TRIF dampens the IFN response. 3Cpro also affects the host innate 
immune response to viral infection by cleaving focal adhesion kinase (FAK) (164) and 
mitochondrial antiviral signaling protein (MAVS) (163), a signaling adapter for MDA5. Others 
have reported that EV71 3Cpro directly inhibits RIG-I function, thereby blocking innate immune 
signaling (165). EV71 3Cpro also efficiently cleaves TRIF in non-polarized HeLa and 
rhabdomyosarcoma cells, to silence TLR3-mediated sensing, but fails to fully cleave TRIF in a 
polarized epithelial cell line (166) that produces a strong IFN response following challenge with 
EV71 (167). The other viral protease, 2Apro, further ablates antiviral signaling by cleaving MAVS 
(168) and reducing levels of the IFNα/β receptor (IFNAR) (169).  
The disparity in the pathways used by enteroviruses to enter, replicate in, and be released 
from polarized versus non-polarized cells demonstrate that the selection of cell culture model is 
critical in studying enterovirus pathogenesis in different tissues. 
1.3.2 Use and limitations of in vivo models 
As described in the previous section, traditional cell cultures have provided an excellent foundation 
of knowledge for the molecular biology of enterovirus infection. However, the cultures used in 
these studies lack some of the more complex properties of the small intestine that exist in vivo. 
Commonly used cell lines, such as Caco-2 cells, lack the differentiated repertoire of cells that are 
described in section 1.2.2, and are generally used for their properties that resemble those of 
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enterocytes (145). Intestinal carcinoma lines such as Caco-2 and HT29 also lack superstructural 
characteristics of the in vivo intestine such as crypts that are filled with stem and Paneth cells, and 
villi. Likewise, these and other immortalized lines do not undergo the same patterns of 
differentiation as cells in vivo, nor do they progress through the same limited life cycles, in which 
cells migrate out of the crypt towards the villus tips, where they are sloughed off into the lumen in 
a matter of days. 
In vivo studies in mice have been performed to model CVB infection at sites that the virus 
is able to infect after disseminating from the small intestine, including the heart and pancreas. 
Infection in these tissues can be responsible for some of the most severe outcomes of CVB 
pathogenesis including pancreatitis (170), the development of type I diabetes (171), myocarditis, 
and dilated cardiomyopathy (172). To date, there is no effective adult mouse model developed to 
study infection of the intestinal epithelium (173). The pancreatic and cardiac disease models 
require intraperitoneal (IP) infection, which bypasses the intestinal epithelium as an infection 
barrier and fails to model the early events that occur during human infection. An approximately 
10,000-fold greater dose of CVB is required to infect mice via the enteral route (174). The reasons 
for poor oral infectivity of CVB in mice have not been completely established. However, a leading 
hypothesis is that it may be due the inaccessibility of the viral co-receptor, human DAF. As CVB 
does not bind rodent DAF (175), tropism in these animals is likely limited to non-polarized cells 
with CAR that is directly accessible via the intestinal lumen.  
Pan et al. (174) described a murine model for CVB infection in which the DAF gene is 
placed under the murine villin promoter, resulting in DAF expression that is restricted to the small 
and large intestines. Furthermore, the localizations of DAF and CAR in this model recapitulate 
what is observed in human epithelial cells, as DAF is properly localized on the apical surfaces of 
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these cells, while CAR is located in tight junctions. The expression of recombinant DAF allows 
for more robust binding and infection of murine duodenum-derived stem cells grown in culture, 
but does not confer permissivity to CVB. Infection is only possible in mice lacking the interferon 
α/β receptor. Similarly, PV has previously been found to replicate more efficiently in poliovirus 
receptor (PVR) expressing transgenic mouse models when the type I interferon system is ablated, 
such as through knockout of IFNAR (176). Unlike with PV, DAF expression does not further 
enhance CVB infection in interferon α/β receptor knockout mice. Further research will be required 
to determine factors in the mouse intestine that are responsible for restricting CVB growth. DAF 
binding may not result in the same cytoskeletal remodeling events in mice as occur in humans. 
Additionally, Pan et al. speculate that it may be possible, though unlikely, that M cells facilitate a 
role in CVB dissemination by allowing transcytosis of the virus in humans. Mice expressing 
recombinant VLA-2, the primary human receptor for enterovirus 1 (E1) (177) are susceptible to 
E1 replication after injection with virus, resulting in CNS infection and paralysis in neonates, while 
infection of adolescent mice results in fatal myocarditis. (178).  
1.3.3 New models to study the differentiated epithelium  
Although many crucial advances in the field of enterovirology have been made in studies using 
two-dimensional (2-D) cell culture monolayer models, standard cultures of intestinal cells are 
limited as they lack villus and crypt formations, as well as fully differentiated, short-lived, 
epithelial cell types. As described in the previous section, transgenic rodent models have proven 
extremely useful in studies focusing on secondary sites of enterovirus infection and pathologies. 
However, due to the differences between rodents and humans and the fact that for many 
enteroviruses there is not an appropriate adult murine model that can be infected via the 
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gastrointestinal tract, such models will never be a complete replacement for studies in human-
based cell systems.  
Three-dimensional (3-D) culturing techniques for immortalized cell lines result in the 
enhanced features of polarized cells that are lost in typical culturing on plastic or glass, due to 
gravitational forces and the lack of proper fluid shear dynamics. As discussed, it is already known 
that properties of polarized intestinal cells are responsible for significant changes in the course of 
CVB infection, including the processes of entry and cell lysis, compared to infection in non-
polarized cells. Therefore it is imperative to have a model with fully polarized cells including 
properly formed junctions, apical, and basolateral surfaces. Additionally, the intestinal epithelium 
is a complex and differentiated environment. This multicellular complexity, which does not occur 
in cultured cells (179), includes enterocytes as well as antimicrobial-producing Paneth cells, 
mucus-secreting goblet cells, and M cells that are responsible for the transcytosis of molecules 
from the lumen across the epithelial barrier.  
Cells grown using advanced culturing systems have been shown to recapitulate certain 
aspects of the human intestines that are lost in standard culturing, including junctional 
organization, brush border formation, and the development of multicellular complexity (180). 
Transwell filters have been utilized for many years to study polarized cell types. This technique 
involves culturing cells on permeable membranes, allowing the manipulation and collection of the 
medium and its contents in separate apical and basolateral compartments. As reviewed by 
McCormick (181), transepithelial models can be used to study aspects of cell barriers, including 
M cell transcytosis, the translocation of bacteria, tight junction function and permeability, and the 
transmigration of infiltrating neutrophils as a result of chemokine release following infection. 
Additionally, transwell setups can be used to model co-cultures, with other cell types in contact 
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with either the apical or basolateral surface of the epithelium. However, as transwell filters are 
relatively flat and lack 3-D scaffolding, they do not allow for the development of more complex 
tissue architectures such as intestinal crypts and villi.  
Recent advances in microfluidic cell culture technology offer much promise for producing 
functional gut models. As with transwell filters, cells are grown on porous membranes, but fluidic 
channels provide peristaltic motion over the cell surfaces to generate physiologically relevant 
levels of mechanical shear force (182). This results in the a functional barrier and the development 
of markers of differentiation for the four major types of Lgr5+ derived lineages (enterocytes, 
goblet, enteroendocrine, and Paneth cells) as well as villi and proliferative crypts. This technology 
is still relatively early in development. In addition to requiring expensive hardware, the setup is 
limited in scale. A single chip and membrane are useful for one experimental sample. Experiments 
requiring, for instance, multiple controls and separate samples across an array of time points might 
not be feasible for many researchers. Nonetheless, microfluidic chambers represent an exciting 
new avenue in intestinal cell culture technology that will no doubt continue to advance in the 
coming years. 
A major advancement in cell culture was the development of microcarrier beads. These 
products serve as scaffolding to eukaryotic cells and, when grown in suspension, allow cells to 
grow without the restriction of gravitational force hindering structure development, while also 
maximizing surface area for cell growth (183). These beads are composed of cross-linked dextran 
(referred to commercially as Sephadex). In 1987, a modified version of these microcarriers, 
Cytodex-3 beads, was developed that is further enhanced with an outer coating of collagen that 
serves as extracellular matrix (ECM), promoting their adherence to epithelial basolateral 
membranes (184). This system was quickly adopted for the purpose of efficiently growing 
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mammalian viruses including simian virus 40 (SV40), murine leukemia virus (MuLV), Sindbis, 
and VSV (185). It has also been used to study non-viral pathogens including the obligate 
intracellular parasite, Chlamydia trachomatis (186, 187). These and other early studies involving 
microcarrier beads were performed in “spinner flasks” to keep cells and carriers suspended. 
However, this relatively aggressive suspension technique does not resemble the intestinal 
microenvironment, and the large amount of turbidity it generates can be detrimental to the 
development of more delicate formations such as intestinal villi.  
1.3.3.1 The rotating wall vessel bioreactor. One apparatus that has become widely used for the 
3-D culturing of a multitude of different cell and tissue types is the rotating wall vessel bioreactor 
(RWV), a device that was originally developed by NASA to simulate conditions of microgravity 
(188). This relatively simple apparatus consists of a motorized platform that is connected to slow 
turning lateral vessels (STLVs) containing cell and bead suspensions. These vessels rotate 
constantly at a pre-set speed, such that the beads are in a perpetual freefall that resembles the 
conditions of microgravity. The entire unit is placed within a cell culture incubator and air is 
pumped by the bioreactor into the STLV, where it diffuses across an interior membrane and into 
the cell culture medium. The absence of large bubbles leads to low levels of turbidity, thereby 
promoting tangential laminar flow and reducing the risk of cell damage (189). Cells adhere to the 
collagen coated beads and, over the course of three weeks, divide until they form confluent layers 
encompassing the bead surfaces. At the end of the culturing period, the cell-covered beads are 
removed from the STLV and can then be transferred to standard cell culture surfaces such as plastic 
24-well plates and chamber slides or harvested for RNA, protein, or imaging. 
As reviewed by Hammond and Hammond (189), the reduced gravitational pressure, low 
turbulence, and near physiological laminar fluid-shear forces contribute to the differentiation of 
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cells from several organ systems. Cell types that have been used in the RWV include small 
intestinal epithelial cells (190), placental trophoblasts (191), hepatocytes (192), lung alveolar 
epithelial cells (193), cardiomyocytes (194), skeletal muscle (195), lymphoid tissue (196), renal 
cells (197), osteocytes (198), and salivary glands (199). This system allows for reproducible 
studies, such as the development of infection models for a variety of pathogens (reviewed in (179)) 
for in vitro studies that more closely recapitulate characteristics of the equivalent cell types as they 
occur in vivo. Once removed from the STLV, cells retain their differentiated status for several 
days, during which assays can be performed in much the same ways as with standard 2-D cells. 
Some of the early host-pathogen studies in the RWV/Cytodex system were performed by 
Cheryl Nickerson’s laboratory at Arizona State University and focused on Salmonella enterica 
serovar Typhimurium pathogenesis in the human intestine using Int-407, HT29, and Caco-2 cell 
lines (180). Introduction of Salmonella to 3-D cultures resulted in comparatively lower levels of 
adherence, invasion, and induction of cell death compared to 2-D cultures, as well as altered 
cytokine signaling including lower levels of inflammatory tumor necrosis factor α (TNFα) 
induction (190). Additional studies determined that cells grown in 3-D differ from those in 2-D 
and more closely resemble what has been reported in vivo in that they could be invaded by 
Salmonella mutants lacking a type III secretion system (200-202). Other groups have made use of 
the RWV to assess invasion and hemolytic activity of uropathogenic E. coli in bladder cells (203). 
In another study, Pseudomonas aeruginosa was shown to penetrate 3-D alveolar epithelial cells 
better than 2-D cultures and induce greater levels of pro-inflammatory cytokines (193).  
Several studies have demonstrated the usefulness of the RWV bioreactor for viral infection 
in specific tissue types. Our lab has found that the human placental cell line, JEG-3, can be co-
cultured with human endothelial cells in 3-D to produce a differentiated human placenta model 
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that contains both the cytotrophoblast and syncytiotrophoblast type cells that are present in vivo 
(191). These 3-D cultures have syncytia, brush borders, and produce physiologically relevant 
hormones such as β-human chorionic gonadotropin (βhcg). The placenta is the critical barrier 
responsible for protecting the unborn fetus from pathogens present in the mother. Our lab’s results 
show that 3-D JEG-3 cultures constitute a better barrier to infection against vesicular stomatitis 
virus (VSV) and the eukaryotic parasite, Toxoplasma gondii.  
Epstein-Barr virus (EBV) is a gammaherpesvirus and the causative agent of infectious 
mononucleosis. EBV is characterized by distinct cycles in which it is either actively growing in a 
lytic phase or dormant in its latent phase, allowing it to permanently persist in an infected human. 
Reactivation of EBV into its lytic cycle and the production of higher than typical viral titers has 
been observed in spaceflight, and thus it has been hypothesized that microgravity may affect 
reactivation. However it was discovered that, in a lymphoblastoid model, EBV reactivation was 
further suppressed in conditions of microgravity compared to 2-D culturing (204). Brinley et al. 
suggested that other factors such as radiation and stress may be important, and their results 
demonstrate that gamma radiation plays a larger role in reactivation of EBV from 3-D grown cells 
(205). Another herpesvirus with active and latent infections is varicella zoster virus (VZV), which 
infects neurons and results in chickenpox or, upon reactivation, shingles. Although 2-D cultures 
are rapidly destroyed by VZV, a recent study shows that long-lived neuron-like 3-D cultures can 
harbor persistent VZV infection for over three months (206). 
Another group produced a productive infection model for hepatitis C virus (HCV), using 
Huh7 liver hepatoma cells that grow into more complex 3-D aggregates with better polarization 
than their 2-D counterparts, including HCV receptors that are concentrated on the apical cell 
surfaces (192). Human noroviruses are notoriously difficult to culture in vitro and efforts to find a 
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suitable cell type, in which productive infection can be established, have been unsuccessful (207). 
One group reported success in generating norovirus-susceptible cultures by utilizing the RWV 
(208), and productive infection resulting in progeny virions (209). However, others have failed to 
produce the same results (210). 
1.3.3.2 Human intestinal enteroids As described in the previous section, 3-D cell culture models 
produced with the RWV can be useful for studying aspects of viral infection that are dependent on 
polarization such as entry and release. However, they are limited in several ways when compared 
to the small intestinal epithelium as it exists in vivo. Single layers of confluent cells form on 
microcarrier beads in the first several days of culturing and persist for the remainder of the 
culturing period of up to 21 days. Cells in small intestinal villi in vivo, on the other hand, 
differentiate, migrate out of crypts, and are sloughed off into the lumen all in the span of only 2-3 
days, while being continually renewed from CBCs at the crypt bases (211). As a cell line, Caco-2 
do not contain CBCs and are typically used as a proxy specifically for enterocytes (212). Therefore, 
though 3-D Caco-2 cells that differentiate to resemble other epithelial types can be useful due to 
production of mucins and other markers, they might not represent the same discrete lineages that 
develop under natural pathways in vivo. Immortalized cell lines also frequently have chromosomal 
aberrations. The ATCC reports that Caco-2 cells have variable karyotypes, featuring 90-106 
chromosomes during metaphase as well as lengthened chromosome arms, translocations between 
chromosomes, and intra-chromosomal rearrangements (213). 
In 2009, a new murine intestinal cell culturing method was developed by Hans Clevers and 
Toshiro Sato’s group (214). In this system, murine intestinal crypts are isolated and plated onto 
Matrigel in standard plastic or glass cell culture ware. Matrigel promotes the adherence of crypt 
basolateral surfaces by mimicking the α1 and α2 laminins that are present in the basement 
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membrane in vivo and are important for the crypt-mesenchyme connection (215). Non-adherent 
cells including villi and connective tissue are washed away, leaving only replicative crypts. The 
cultures are then grown in the presence of physiologically relevant growth factors: Wnt3a, R-
spondin, epidermal growth factor (EGF), and Noggin. As described in section 1.2.2, Wnt3a 
signaling is critical for the differentiation and maintenance of CBCs as well as crypt growth (216). 
R-spondin functions to amplify Wnt signaling. Noggin regulates BMP signaling, encouraging 
crypt development (217), while EGF promotes proliferation of TAs and villus production (218). 
After growing for several days in the presence of these growth factors, Lgr5+ CBCs differentiate, 
giving rise to the full repertoire of functional intestinal cell types, and proliferate to form villi. 
These techniques were further developed and expanded, allowing for enteroids cultures to be 
passaged and frozen as stocks, and these protocols have been adapted for use with the colonic 
(colonoids) and gastric (gastroids) epithelia (219-222). In 2011, Sato et al. cultured primary human 
intestinal crypts using a modified form of their murine enteroid model (223). 
Human enteroids recapitulate many features of the small intestine. As reviewed in (224), 
cells in this system become well polarized, with basolaterally localized nuclei, luminal brush 
borders, and tight junction proteins. As with the equivalent murine model, enteroids form crypt 
and villus-like structures, as well as all of the known cell types in the secretory and absorptive 
lineages.  
Although enteroid culturing is a relatively new process, researchers have further 
augmented the technique to make it even more versatile. Enteroids formed from crypts of adult 
small intestine biopsies can be sustained even after repeated passaging in cell culture, and can be 
re-plated on collagen-coated surfaces, where they flatten out into sheets of cells (225). Some 
studies have described the removal of Wnt3a from adult enteroid cultures after several days to 
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simulate the reduction in signal that would be received as cells proliferate away from crypt Paneth 
cells in vivo (218, 223), though conditions for fetal-derived enteroids keep a fixed concentration 
of growth factors throughout the culturing period (226). 
Other groups have modulated the differentiation pathways of enteroid CBCs to produce 
different ratios of epithelial sub-lineages. As detailed in section 1.2.2, the balance between Wnt 
and Notch signaling controls the ratio of absorptive to secretory cells that differentiate from crypt 
CBCs. After induction by Notch, Hes1 promotes absorptive cell development, while repressing 
expression of the essential secretory lineage transcription factor Atoh1 (95). The use of γ-
secretase/Notch inhibitors, such as dibenzazepine (DBZ), has proven to be effective at driving 
intestinal cell differentiation to enrich secretory cell production in an Atoh1-dependent manner 
(92, 227, 228) and this has proven to be effective in enteroid cultures (229). As with cell lines, 
enteroids can also be driven to differentiate into M cells by culturing with RANKL (230). 
Interestingly, Salmonella enterica serovar Typhimurium is also capable of inducing M cell 
differentiation in the enteroid model (230). As described in section 1.2.3, Typhimurium’s ability 
to enter the epithelium depends on transcytosis performed by M cells. 
There have been other studies published utilizing the enteroid system to model 
pathogenesis in the gut. Enteroids have been proposed as a model for induced diarrhea, as they 
express the sodium transporter Nhe3, which is required for intestinal electrolyte homeostasis (231). 
Inhibition of Nhe3 results in diarrhea, and some early results suggest that cholera toxin (CTX) 
produced by Vibrio cholerae disrupts sodium uptake in the enteroid model (224). Diarrhea is also 
a hallmark symptom of rotavirus infection. Saxena et al. utilized an adult human jejunal enteroid 
model and determined that rotavirus infection, or exposure to the rotavirus nonstructural protein 
4, induces luminal fluid secretion (232). Additionally, the differentiated enteroid model allowed 
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them to determine that enterocyte and enteroendocrine cells were infected by rotavirus, but not 
goblet cells. A recent publication from the same laboratory establishes enteroids as a productive 
model for norovirus infection (233). As stated in section 1.3.3.1, the field of human norovirus 
molecular biology has long been faced with the challenge of producing infection in vitro that 
results in the release of infectious virus. Ettayebi et al. found that some strains of norovirus require 
the presence of bile or epithelial cell secretor status to replicate in enteroids, while others did not. 
Finally, human enteroids have been used to study the ability of infectious proteins, prions, to cross 
the intestinal barrier (234). In mice, the ability for prions delivered orally to infect the CNS was 
entirely dependent on uptake of the proteins by M cells (118).  
For the reasons outlined in this section, the human epithelial enteroid model is an 
important, physiologically relevant system for studying the aspects of the small intestine, including 
infection by enteric pathogens. 
New methods of growing intestinal epithelial cells in culture offer numerous advantages 
over the traditional types of monolayer-based cultures that are often the de facto standard for in 
vitro studies in epithelial pathogenesis. In chapters 2 and 3, I will describe our lab’s recent findings 
that were based on utilization of the RWV bioreactor and human primary cell derived enteroids, 
respectively, in order to gain insight into enterovirus infection, as well as cellular responses in the 
intestinal epithelium. 
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2.0  A THREE-DIMENSIONAL CELL CULTURE MODEL TO STUDY 
ENTEROVIRUS INFECTION OF POLARIZED INTESTINAL EPITHELIAL CELLS 
Coxsackievirus B (CVB) is associated with meningitis, pericarditis, diabetes, dilated 
cardiomyopathy, and myocarditis, amongst other pathologies. CVB is transmitted via the fecal-
oral route and encounters the epithelium lining the gastrointestinal tract early in infection. Little is 
known about CVB infection of the intestinal epithelium, despite its role as the primary portal in 
pathogenesis, owing at least in part to the lack of suitable in vivo models and the inability of 
cultured cells to recapitulate the complexity and structure associated with the GI tract.  
Here, we report on the development of a 3-D organotypic cell culture model of Caco-2 
cells to model CVB infection of the gastrointestinal epithelium. We show that Caco-2 cells grown 
in 3-D using the RWV bioreactor recapitulate many of the properties of the intestinal epithelium, 
including the formation of well-developed tight junctions, apical-basolateral polarity, brush 
borders, and multicellular complexity. In addition, transcriptome analyses using transcriptome 
sequencing (RNASeq) revealed the induction of a number of genes associated with intestinal 
epithelial differentiation and/or intestinal processes in vivo when Caco-2 cells were cultured in 3-
D. Applying this model to CVB infection, we found that although the levels of intracellular virus 
production were similar in 2-D and 3-D Caco-2 cell cultures, the release of infectious CVB was 
enhanced in 3-D cultures at early stages of infection. Unlike CVB, the replication of PV was 
significantly reduced in 3-D Caco-2 cell cultures. Collectively, our studies show that Caco-2 cells 
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grown in 3-D using the RWV bioreactor provide a cell culture model that structurally and 
transcriptionally represents key aspects of cells in the human GI tract. By utilizing this 3-D model 
to the study of CVB infection, our work provides a new cell system to model the mechanisms by 
which CVB infects the intestinal epithelium, which may have a profound impact on CVB 
pathogenesis. This model can therefore be used to expand our understanding of enterovirus-host 
interactions in IECs. 
2.1 INTRODUCTION 
Enteroviruses, small positive-strand ssRNA viruses of the Picornaviridae family, are primarily 
transmitted by the fecal-oral route and encounter the epithelium lining the GI tract early in 
infection. IECs form formidable barriers to pathogen entry, owing in part to the highly 
differentiated and complex nature of their apical surfaces, which are composed of rigid densely 
packed microvilli coated with a mucin-enriched glycocalyx, and the presence of junctional 
complexes between cells that restrict pathogen access to the interstitial space. In addition to the 
barrier presented by enterocytes themselves, the multicellular nature of the GI epithelium, which 
is composed of goblet cells, Paneth cells, and M cells, the latter of which are found in Peyer’s 
patches, also serve to restrict pathogen entry. Little is known regarding the events that surround 
enterovirus infection of the GI tract owing at least in part to the lack of suitable in vivo models for 
the enteric entry route of these viruses and to the inability of standard cultured cells to recapitulate 
the complexity and structure associated with the gastrointestinal epithelium. 
The lack of enterovirus infection following oral administration in mice has been attributed 
to the inability of many of these viruses to bind to the murine homologs of their entry receptors 
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and/or attachment factors (235-237). However, poliovirus (PV) replicates inefficiently in mice 
expressing the human poliovirus receptor and exhibits higher levels of replication when the type I 
IFN system is ablated by deletion of the IFNα/β receptor (176). Similarly, expression of DAF, 
which serves as an attachment factor for CVB (236, 238) and is required for apical infection of 
cultured enterocytes (239), is also not sufficient to mediate high levels of viral replication when 
the virus is delivered by the enteral route, which only occurs upon IFNα/β receptor deletion (174). 
In addition, although murine models have been developed for both CVB-induced pancreatitis (240, 
241) and cardiomyopathy (172, 242), these models require intraperitoneal infection, thus 
bypassing IECs as an infection barrier.  
Based upon cell culture models, there are several key differences between the mechanisms 
by which CVB infects polarized IECs and non-polarized cells, such as HeLa cells. The polarized 
nature of IECs poses an inherent complexity for CVB entry. CVB utilizes DAF as an apical 
attachment factor and requires delivery of apically-bound viral particles to the TJ complex to 
interact with its entry receptor, CAR (147, 243). In polarized IECs, CVB accomplishes this through 
hijacking the cytoskeleton and inducing intracellular tyrosine family kinase signaling, which 
results in virus delivery to the TJ and eventual access to the cytoplasm by caveolar- and 
macropinocytosis-associated pathways (147, 148). In non-polarized cells, CAR is readily 
accessible to viral particles and does not require DAF for attachment or entry (239). Accordingly, 
the mechanism of entry differs dramatically from IECs (244). Post-entry, CVB replication is also 
facilitated by IEC-specific factors (158) and CVB egress from IECs is mediated by a different cell 
death pathway from that observed in non-polarized cells (153). Collectively, these previous studies 
have pointed to important differences in the life cycle of CVB between polarized IECs and non-
polarized cells and suggest that these differences play important roles in viral pathogenesis. 
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Although the use of cultured intestinal cells has provided the foundation for much of what 
we know about CVB infection of polarized IECs, an inherent limitation with these cell systems is 
their inability to recapitulate the architecture and multicellular complexity associated with the 
human GI tract. The culturing of many enteric cell lines in 3-D has provided an excellent model 
system to mimic the morphological and/or functional features of these cells in vivo and to better 
model their susceptibility to microorganisms (reviewed in (179)). The RWV bioreactor, which was 
initially developed by NASA to recapitulate aspects of the quiescent microgravity environment, 
has emerged as an advantageous method to culture cells in 3-D as it recapitulates physiologically 
relevant, low levels of shear and turbulence (179, 188, 245). Enteric cell lines cultured in this 
system exhibit many characteristics normally associated with fully differentiated functional IECs 
in vivo, including distinct apical and basolateral polarity, increased expression and better 
organization of TJs, enhanced expression of brush border proteins, and highly localized expression 
of mucins, and also exhibit multicellular complexity (including the presence of M/M-like cells, 
goblet cells, Paneth cells, and enterocytes), which does not occur using standard 2-D culture 
systems (179, 180, 200-202, 246, 247). Enterocytes cultured in this system also display important 
differences from 2-D cultured cells with respect to their susceptibility to bacterial attachment and 
invasion. For example, Salmonella enterica serovar Typhimurium exhibits reductions in its ability 
to adhere to IECs grown in 3-D (190) and exhibits reduced invasion in IECs cultured in 3-D (190, 
200). In addition to intestinal models, the structural complexity of other cell types grown in 3-D 
has resulted in the development of infection models for a diverse array of pathogens and tissue 
types (reviewed in (179)), including Hepatitis C Virus in hepatocytes (192), Pseudomonas 
aeruginosa and Francisella tularensis in the alveolar epithelium (193), and HIV in lymphoid tissue 
(196).  
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Given the lack of suitable in vivo models of CVB enteric infection, we utilized the RWV 
bioreactor to develop a 3-D culture system of human IECs to better model their infection by CVB. 
Caco-2 cells were chosen as the cell type to use in this model given that they have previously 
served as a cell culture model for CVB infection of IECs in vitro (147, 148, 153, 158) and have 
been used previously in the RWV bioreactor (209, 210). We found that Caco-2 cells cultured in 3-
D using the RWV Bioreactor displayed morphological and transcriptional changes more similar 
to the GI epithelium in vivo. Strikingly, we found by RNASeq transcriptome analyses that Caco-2 
cells cultured in 3-D robustly express transmembrane mucins that form the enterocyte apical 
glycocalyx and specific markers of goblet and enterocyte cell differentiation, whereas these 
transcripts are not expressed or are of low abundance in 2-D cultures. In addition, we show that 
Caco-2 cells grown in 3-D are susceptible to CVB infection, but produce lower levels of viral RNA 
(vRNA) and newly synthesized viral protein compared to cells cultured in 2-D. However, despite 
the lower levels of vRNA and viral protein, we found that intracellular titers of CVB were similar 
between 2-D and 3-D cultures. Interestingly, we also found that CVB was released into the medium 
of infected Caco-2 cells cultured in 3-D more efficiently at earlier time points than what was 
observed in 2-D cultured cells, suggesting that viral release may occur with greater efficiency in 
this model. Given the significant morphological and expression changes induced in Caco-2 cells 
grown in 3-D, and their susceptibility to CVB infection, this system can be used to better model 
the interaction of CVB, and possibly other viruses, with polarized IECs.  
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2.2 MATERIALS AND METHODS 
Cell culture  
Caco-2 cells (ATCC clone HTB-37) were cultured in modified eagle’s medium with 10% fetal 
bovine serum, non-essential amino acids, penicillin/streptomycin, and sodium pyruvate. HeLa 
cells (CCL-2) were grown in modified eagle’s medium with 5% fetal bovine serum, non-essential 
amino acids, penicillin/streptomycin, and sodium pyruvate. 
 
Rotating wall vessel bioreactor cultures 
For 3-D culturing, Caco-2 or HeLa cells were grown in the slow turning lateral vessel (STLV, 
Synthecon Inc.) bioreactor system, based on previously established protocols (201, 209, 210). 
Cells were grown to confluence in standard 2-D flasks, and removed with 0.05% trypsin-EDTA, 
enumerated using a TC20 Automated Cell Counter (Biorad0, and combined with 250 mg Cytodex-
3 beads (Sigma Aldrich) in 55 mL of complete medium. The bead/cell mixture was then added to 
a sterile STLV and incubated at 37ºC under static conditions for one hour before attachment to the 
Rotary Cell Culture System 4H (Synthecon Inc.). The reactor was rotated at a speed of 20 RPM 
within a humidified incubator, at 37ºC and 5% CO2 for the duration of the culture period. Culture 
medium was replaced five days after the initial STLV seeding, and every two days thereafter. Cell-
covered beads were removed for analysis or infection on day 21, unless otherwise stated and 
transferred to 24-well tissue culture plates for infection and subsequent experiments. To calculate 
cell number per volume of beads, cells were removed with 0.05% trypsin-EDTA at 37oC and 
enumerated as described above. In parallel, control 2-D cells from monolayers were also seeded 
into 24-well plates. In both cases, 4x105 cells were seeded per well.  
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Viruses and plaque assays 
Experiments were performed with CVB3-RD or PV, expanded as described (248, 249) with 1-3 
plaque forming units (PFU)/cell. For all infections, virus was adsorbed to cells for one hour at 
16ºC followed by removal of unbound by washing with PBS. Complete cell medium was then 
added and cells were incubated at 37ºC throughout the period of infection. Samples were collected 
at the indicated times. For plaque assays, CVB-infected Caco-2 or HeLa cells were harvested at 
the indicated times by cell scraping. In parallel, supernatants were collected to quantify 
extracellular CVB titers. Samples were freeze-thawed three times and viral titers determined by 
plaque assays as described previously (153).  
 
Immunofluorescence Microscopy 
Cells were washed with PBS and fixed with 4% paraformaldehyde or with ice-cold 100% methanol 
followed by permeablization with 0.25% Triton X-100 in PBS and incubation with the indicated 
primary antibodies for 1-2 hrs at room temperature. Following washing, cells were incubated with 
secondary antibodies for 30 min at room temperature, washed, and mounted with Vectashield 
(Vector Laboratories) containing 4′,6-diamidino-2-phenylindole (DAPI). Images were captured 
using a FV1000 confocal laser scanning microscope (Olympus) and contrasted and merged using 
Photoshop (Adobe). Antibodies or other reagents for fluorescence microscopy were as follows: 
mouse anti-enterovirus VP1 (NC-ENTERO, Leica), mouse anti-ZO-1 (Mid, Invitrogen), mouse 
anti-Ezrin (Millipore), rabbit anti-occludin (N-term, Invitrogen), mouse anti-β-catenin 
(Invitrogen), mouse anti-GLUT5 (Sigma), rabbit anti-E-cadherin (Invitrogen), rabbit anti-GAPDH 
(Santa Cruz Biotechnology), and FITC-conjugated ulex europaeus agglutinin I (UEA1, Sigma). 
Rabbit anti-CAR (45) and mouse anti-DAF IF7 were kindly provided by Jeffrey Bergelson, 
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Children’s Hospital of Philadelphia. Alexa Fluor conjugated secondary antibodies were purchased 
from Invitrogen.  
 
Electron Microscopy  
Cells were fixed in 2.5% glutaraldehyde, washed with PBS, and postfixed in aqueous 1% OsO4. 
After washing in PBS, samples were dehydrated through a graded ethanol series (30%-100%) and 
washed with absolute ethanol before drying in Hexamethyldisilizane solution followed by air-
drying.  For 3-D cultures, beads were picked up with double sided copper tape. Cells were 
subsequently embedded in epon resin and thin sectioned for imaging utilizing a JEOL 1011 
transmission electron microscope, or subjected to critical point drying and mounted on aluminum 
stubs for imaging with a scanning electron microscope (JSM 6330F). 
 
Immunoblotting 
Protein lysates were collected in RIPA buffer (50 mM Tris-HCl, 1% NP-40, 0.25% sodium 
deoxycholate, 150 mM NaCl 1 mM EDTA) containing a protease inhibitor cocktail (Promega). 
Lysates were separated on 4-20% gradient Tris-HCl SDS-PAGE gels, transferred to nitrocellulose 
membranes, and blocked for one hour in 5% milk PBS with (0.5%) Tween-20 (PBST). Following 
washing, membranes were incubated with anti-rabbit or anti-mouse antibodies conjugated to 
IRDye 680LT or 800CW and visualized with the Odyssey Infrared Imaging System.  
 
RNASeq 
Total RNA was extracted using GenElute™ Mammalian Total RNA Miniprep Kit (Sigma) 
according to the manufacturer’s protocol. RNA samples were treated with RNAse-free DNAse 
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(Sigma). RNA integrity was assessed by Nanodrop, Qubit assay, and/or using a Agilent2100 
Bioanalyzerm as per each manufacturer’s specifications.  Sample amounts were normalized and 
1000ng used for library preparation using the NEB Ultra RNA Library Preparation Kit as per the 
manufacturer’s instructions.  Library QC and quantitation was performed on all individual libraries 
by the Qubit assay and the Agilent2100 Bioanalyzer.  Libraries were normalized and pooled via 
Qubit measurement.  The final pool was quantitated via qPCR.  Sequencing was performed on the 
Illumina HiSeq2500 Rapid Run Mode on 1 flowcell (2 lanes) as per the system manufacturer. Raw 
RNAseq data were processed, normalized, and mapped to the human reference genome (hg19) 
using CLC Genomics Workbench 8 (Qiagen). Differentially expressed genes were identified using 
DESeq2 (250) with the indicated significance cut-offs. Hierarchical clustering was performed 
using Cluster 3.0/Java Treeview and heat maps generated using MeViewer software (17). 
 
Quantitative PCR 
Total RNA was extracted using GenElute™ Mammalian Total RNA Miniprep Kit (Sigma) 
according to the manufacturer’s protocol, were treated with RNAse-free DNAse (Sigma), and were 
reverse transcribed using iScript™ cDNA Synthesis Kit (Bio-Rad). For each sample, 1μg total 
RNA was used for cDNA synthesis. RT-qPCR was performed using iQ™ SYBR® Green 
Supermix (Bio-Rad) in an Applied Biosystems StepOne real-time PCR machine. Gene expression 
was calculated using a modified ΔCT method based upon normalization to human actin. Primer 
sequences can be found in Supplemental Table 1.  
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Neutral Red Assay 
Neutral red containing CVB particles were prepared as described previously (158, 251). To 
synchronize infections, NR-CVB (10 PFU/cell) was adsorbed to cells at 16ºC for one hour prior 
to incubation in dark conditions at 37ºC in a humidified incubator. Following infection for 0-3hrs, 
cells were illuminated for 20 minutes on a light box cells were exposed to light for 20 minutes or 
kept in semi-dark conditions for the duration of the infection (~18hr). Infection was quantified by 
RT-qPCR, as described above.  
 
DAF Immunoblocking Assay 
Cells were pre-incubated with anti-DAF IF7 at a dilution of 1:50, or an isotype control antibody 
for one hour prior to CVB infection, as described previously (239). Cells were then infected with 
CVB (1 PFU/cell) for ~5hrs and infection was quantified by RT-qPCR, as described above.  
 
HMGB1 Enzyme-linked Immunosorbent and Lactose Dehydrogenase Release Assays 
Cellular supernatants were collected from 2-D and 3-D Caco-2 cells at 0, 6, 10, 24, and 48 hours 
post-infection. Levels of released HMGB1 were measured utilizing an HMGB1 ELISA kit (IBL-
International) per the manufacturer’s instructions. Levels of released LDH in cellular supernatants 
were measured using the LDH Cytotoxicity Assay Kit (Pierce),per the manufacturer’s protocol. 
 
Statistics 
All statistical analysis was performed using GraphPad Prism. Student’s t-test or one-way ANOVA 
were performed as appropriate.  * indicates p<0.05. ** indicates p<0.01. *** indicates p<0.001, 
unless otherwise noted.  
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2.3 RESULTS 
2.3.1 Establishment of Caco-2 3-D cultures using the RWV Bioreactor 
The RWV bioreactor consists of slow-turning lateral vessels (STLVs), which are completely filled 
with cell culture medium and contain cells attached to porous, extracellular matrix (ECM)-coated 
beads (or other scaffolds) (188) (schematic, Figure 2A). STLVs are kept in constant rotation by a 
powered apparatus, allowing for cells and beads to remain in perpetual suspension. We established 
this system for Caco-2 cells using collagen-coated porous dextran beads (Cytodex-3) and cultured 
cells for a period of 21-days prior to their removal from the STLVs and subsequent processing for 
downstream applications (schematic, Figure 2A). We found that Caco-2 cells fully coated Cytodex 
beads during the culture period and formed complete, uniform single layers of cells and organoids 
composed of cell-bead aggregates as assessed by both scanning and transmission electron 
microscopy (SEM and TEM, Figures 2B, 2C).  
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Figure 2. (A) Schematic for the culturing of cells in the RWV bioreactor. Slow-turning lateral vessel (STLV). Green 
spheres in schematic represent cell-coated Cytodex beads. (B), Scanning electron micrograph (SEM) of Caco-2 cells 
cultured in the RWV bioreactor for 21 days. (C), Transmission electron microscopy (TEM) of Caco-2 cells cultured 
in the RWV bioreactor for 21 days. Black arrow denotes the apical surface. (D), Confocal microscopy for GLUT5 
(green) in 2-D or 3-D Caco-2 cultures. At top, XY image and at bottom, XZ cross-section. DAPI-stained nuclei are 
shown in blue. (E), Confocal microscopy for UEA1 (green) in 2-D or 3-D Caco-2 cultures. White arrows denote 
specific sites of fluorescence in 3-D beads. At bottom, cross-section of 3-D culture. DAPI-stained nuclei are shown in 
blue. In (D) and (E), scale bar is 10μm. 
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 Several GI-derived cell lines, including HT-29 and INT-407 cells, develop multicellular 
complexity (including the presence of M/M-like cells, goblet cells, Paneth cells, and enterocytes) 
when cultured in 3-D (179, 180, 200-202, 246, 247). To assess the differentiation of RWV-cultured 
Caco-2 cells, we performed fluorescence confocal microscopy for markers of IEC subtypes. We 
used an antibody directed against GLUT5, a fructose transporter of the SLC2 family which 
localizes to the lumen of human enterocytes (252) and fluorescein thiocyanate (FITC)-conjugated 
lectin, Ulex europaeus agglutinin I (UEA1), which binds L-fructose present in intestinal mucin 
and is associated with M/M-like (253) and goblet cells (254). We found a pronounced 
enhancement of GLUT5 immunofluorescence in 3-D versus 2-D cultured Caco-2 cells, which 
correlated with the pronounced redistribution of GLUT5 from intracellular punctae in 2-D cultures 
to the apical surface in 3-D cultured cells (Figure 2D). Similarly, we found that UEA1 was more 
abundantly expressed on 3-D cultured Caco-2 cells and exhibited an apical localization, consistent 
with its in vivo localization (112) (Figure 2E).  
2.3.2 Caco-2 3-D cultures develop cell-cell junctions and brush borders 
The polarization of IECs protects the interstitial tissue of the lamina propria from foreign 
substances and pathogens in the intestinal lumen. The integrity of the epithelium as a barrier to 
microbial infection depends on properly formed cell-to-cell junctions, which include the apical-
most TJ complex. We found that 3-D cultures of Caco-2 cells developed well-formed TJs, as 
assessed by the localization of the TJ-associated proteins ZO-1 and occludin to cell-cell borders 
(Figure 3A). The presence of cellular junctions was confirmed by TEM, which revealed the 
presence of adjoining membranes between neighboring cells in 3-D cultured cells at the apical-
most domain of the paracellular space (Figure 3B).  
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Figure 3. (A), Confocal microscopy for ZO-1 (green) and occludin (red) in 3-D Caco-2 cells cultured for 21 days. 
DAPI-stained nuclei are shown in blue. (B), Transmission electron micrographs of 3-D cultures of Caco-2 cells. Black 
arrow denotes junctional complex between cells. At right, zoomed image of image shown at left. (C), Confocal 
microscopy for DAF (green) and CAR (red) in 3-D Caco-2 cells cultured for 21 days. DAPI-stained nuclei are shown 
in blue. At top, surface of bead and at bottom, cross-section view of the same bead. In (A) and (C), In scale bar is 
10μm. 
 
The TJs of IECs present an initial barrier to CVB entry as CAR, the viral receptor required 
for CVB uncoating, is localized within these junctions and is inaccessible to the virus from the 
apical surface. CVB can only access CAR and internalize after cytoskeletal rearrangements that 
follow viral binding to the apical viral attachment factor decay DAF (11). Therefore, for an IEC 
model of CVB infection to accurately portray the mechanism of CVB entry, proper localization of 
CAR and DAF are required. We confirmed the asymmetric distribution of the CVB attachment 
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factor DAF to the apical surface and CAR to the junctional complex of 3-D Caco-2 cultures (Figure 
3C), which also occurs in 2-D cultures (147).   
The differentiation of IECs to form well-developed brush borders constitutes a major 
barrier to pathogen infection from the apical surface. To explore the differences in cell 
differentiation in Caco-2 cells grown in 2-D versus 3-D, we assessed the development of brush 
borders by immunofluorescence microscopy for ezrin, a member of the ERM family (ezrin, 
radixin, and moesin) that localizes to microvilli (255), and by SEM. We observed a pronounced 
difference in ezrin localization between Caco-2 cells grown in 2-D versus 3-D—whereas ezrin was 
primarily localized to cell junctions in cells grown in 2-D (Figure 4A), it localized heavily and 
almost exclusively to the apical surfaces of Caco-2 cells cultured in 3-D (Figure 4B). These results 
were corroborated by SEM, which revealed major differences in the development of brush borders 
between cells grown in 2-D versus 3-D, with 3-D cultures exhibiting the typical thin, “finger-like” 
projections of microvilli at their apical surfaces (Figure 4C). 
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Figure 4. (A), Confocal microscopy for Ezrin (green) and occludin (red) in 2-D Caco-2 cells. DAPI-stained nuclei 
are shown in blue. At top, XY image and at bottom, XZ image. (B), Confocal microscopy for Ezrin (green) and 
occludin (red) in 3-D Caco-2 cells. DAPI-stained nuclei are shown in blue. At top, surface of bead and at bottom, 
cross-section view of the same bead. (C), Scanning electron micrographs of 2-D (at left) or 3-D (at right) cultures if 
Caco-2 cells. In (A) and (B), scale bar is 10µm. 
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2.3.3 Transcriptional profiling of 2-D versus 3-D Caco-2 cultures by RNASeq 
To extend the morphologic differences between 2-D and 3-D Caco-2 cultures described above to 
the transcriptome, we performed RNASeq analyses to determine global transcriptional changes 
that occur as a result of culturing Caco-2 cells in 3-D. We observed significant changes in gene 
expression when Caco-2 cells were cultured in 3-D compared to 2-D control cultures (Figure 5A). 
To identify genes whose expression was significantly different upon culturing of cells in 3-D, we 
performed differential expression analysis using DeSeq2 (250). We identified 1596 genes 
(p<0.001) that were differentially expressed between 2-D and 3-D cultures of Caco-2 cells (Figure 
5B, Supplemental Dataset 1). Interestingly, many of the most upregulated genes in 3-D cultures 
are associated with intestinal differentiation and/or play specific roles in intestinal processes 
(Figure 5C). These included gonadotropin-releasing hormone (GnRH)-2 (GNRH2), which was the 
most differentially upregulated gene in 3-D cultures and is expressed primarily in the small 
intestine (256), the transmembrane mucins MUC1, MUC13 and MUC17, which are abundantly 
expressed in the intestine in vivo (112, 257) and form the enterocyte apical glycocalyx, and the 
duodenum and jejunum-associated aquaporin AQP10 (258). In addition, N-acetyllactosaminide 
beta-1,3-N-acetylglucosaminyltransferase-3 and -6 (B3GNT3 and B3GNT6), which are involved 
in glycan regulation, the goblet cell-specific differentiation factor KLF4 (96), and cytokeratin 20 
(KRT20), a specific marker of intestinal differentiation (259), were all significantly upregulated 
in 3-D Caco-2 cultures (Figure 5C). Significantly downregulated genes included the platelet-
derived growth factor family member PDGFRA, the protease-activated transporter SLC10A4, and 
Dickkopf WNT signaling pathway inhibitor 1 (DKK1).   
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Figure 5. (A), Hierarchical clustering heat map of genes expressed in 2-D or 3-D cultures of Caco-2 cells as 
determined by RNASeq. (B), Hierarchical clustering heat map of genes differentially expressed (p<0.001) in 2-D or 
3-D cultures of Caco-2 cells as determined by RNASeq followed by DeSeq2 analysis. (C), Heat map of select markers 
of intestinal differentiation and/or intestinal-specific processes in 2-D or 3-D Caco-2 cultures. The color intensity in 
A-C indicates the level of gene expression (yellow for up-regulation and blue for down-regulation), and grey indicates 
that no RNASeq reads were detected for that transcript in that sample. RNASeq was performed on two independent 
2-D cultures (2D-1 and 2D-2) and two independent 3-D STLVs (3D-1 and 3D-2). (D, E), RT-qPCR analysis of genes 
upregulated (D) or downregulated (E) in 3-D Caco-2 cultures. In (D), data are shown as the fold change in the 
expression of the indicated genes relative to 2-D controls at the indicated days post-culturing in 3-D. In (E), data are 
shown as the percent change in the expression of the indicated genes relative to the levels at day 0 of the 3-D culture 
period. 
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To confirm the results of our RNASeq studies, and to determine the kinetics by which these 
genes were differentially regulated over the culture period of cells grown in 3-D, we performed 
RT-qPCR on a panel of the most upregulated and downregulated genes, using RNA extracted from 
an independent Caco-2 STLV culture at days 5, 11, and 21 after seeding, as well as from Caco-2 
cells prior to STLV seeding (day 0). Analyzing the expression of 11 upregulated genes over the 
course of 3-D culturing, we not only confirmed our RNASeq results, but found that in all cases, 
the induction of these genes occurred between days 11 and 21 of the culture period (Figure 5D). 
We found by profiling the expression of 5 representative downregulated genes that while some 
genes, such as Orm2, SLC38A4, and ALB, were downregulated early (between days 0 and 5) 
following the initiation of 3-D culturing, others (PDGFRA and DKK1) became downregulated at 
later stages  (after day 5) of 3-D culturing (Figure 5E). These results highlight the profound 
transcriptome differences between cells cultured in 2-D versus 3-D and suggest that the alterations 
in gene expression occur at various stages of the culture period.  
2.3.4 Coxsackievirus B infection in 2-D versus 3-D Caco-2 cultures 
Given that we observed significant differences in the morphology and transcriptional profiles of 
cells grown in 2-D versus 3-D, we next assessed whether Caco-2 cells grown in 3-D would exhibit 
any differences in their susceptibility to CVB infection. To do this, we assessed the levels of CVB 
vRNA, protein, and infectious virus production over a period of 24-72hrs post-infection (p.i.). We 
found that Caco-2 cells grown in 2-D produced significantly more CVB vRNA than did cells 
grown in 3-D at all time points tested (between 4-24hrs p.i.) (Figure 6A). In addition, we found 
that there was a slight delay in the appearance of newly synthesized viral protein, as assessed by 
 56 
immunoblotting for the CVB capsid protein VP1, in Caco-2 cells grown in 3-D, and less overall 
VP1 produced at very late stages of infection (72hrs p.i.) (Figure 6B, 6C).  
To determine if the initial lag in CVB replication observed in 3-D cells was due to a delay 
in viral internalization, we performed a neutral red (NR) infection assay. By propagating CVB in 
the presence of the RNA binding dye NR, the virus becomes sensitive to light, which is reversed 
upon viral uncoating and diffusion of NR away from the vRNA (260). We observed equivalent 
levels of light sensitivity of NR-CVB between 2-D and 3-D cultures at 0hr p.i, which was lost in 
both culture conditions by 2hrs p.i.,indicating that uncoating had occurred in both 2-D and 3-D 
cultures by 2hrs p.i. (Figure 6D). This is consistent with previous work demonstrating that CVB 
undergoes uncoating between 90-120min p.i. in Caco-2 cells in 2-D (147). In addition, similar to 
previous work in 2-D Caco-2 models (239), we found that DAF was required for CVB infection 
of Caco-2 cells in 3-D given that infection was inhibited in both 2-D and 3-D cultures by a 
monoclonal anti-DAF antibody that blocks CVB binding (Figure 6E). Importantly, the levels of 
CAR and DAF were near equivalent in 2-D and 3-D cultures as assessed by RNASeq, thus receptor 
expression does not impact infection levels (Supplemental Figure 1).  
We next profiled the levels of CVB replication in 2-D and 3-D Caco-2 cultures by 
measuring intracellular and extracellular infectious virus titers between 0-48hrs p.i. We found that 
whereas intracellular titers of CVB were near equivalent between 2-D and 3-D Caco-2 cultures at 
all time points tested, there was a substantial enhancement in the release of infectious CVB from 
cells cultured in 3-D at early time points (6-12hrs p.i.) (Figure 6F).  Taken together, these data 
show that CVB enters and infects Caco-2 cells grown in 3-D and can be released from cells 
cultured in 3-D with greater efficiency at early time points of infection compared to cells cultured 
in 2-D. 
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Figure 6. (A), RT-qPCR analyses of vRNA levels of 2-D and 3-D Caco-2 cultures infected with CVB (10 PFU/cell) 
at the indicated hours post-infection. Data are shown as a fold change from 0hr p.i.  (B), LICOR immunoblots for VP1 
(green, top) and GAPDH (red, middle) from 2-D and 3-D Caco-2 cultures infected with CVB (10 PFU/cell) at the 
indicated hours post-infection. Shown are representative data from a single (of three total) STLVs. (C), Densitometry 
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from immunoblots shown in (B). Data are shown as the levels of VP1 normalized to GAPDH at he indicated times 
p.i.  (D), RT-qPCR analyses of CVB vRNA from 2-D or 3-D cultures of Caco-2 cells infected with light sensitive 
neutral red (NR)-containing CVB (1PFU/cell) and exposed to light at the indicated hours post-infection (HPI). In 
parallel, cultures were infected with NR-CVB in the dark. Data are shown as fold change from dark only control 
infections. (E), RT-qPCR analyses of CVB vRNA from 2-D or 3-D cultures of Caco-2 infected in cells pre-treated 
with a control monoclonal antibody (mAb, grey) or anti-DAF IF7 blocking monoclonal antibody (blue). Data are 
shown as fold change (mean ± standard deviation) from control mAb. (F), CVB titers (pfu/mL) of virus collected 
from the medium (Extra, dashed lines) of 2-D or 3-D cultures of Caco-2 cells infected with CVB for the indicated 
hours post-infection. In addition, CVB titers from cells (Intra, solid lines) from CVB-infected 2-D or 3-D cultures are 
shown. Data in (A, D-F) are shown as mean ± standard deviation and are averaged from three (A, F) or two (D, E) 
independent STLVs, *p<0.05, ns (not significant) as determined by a Student’s t-test. 
2.3.5 2-D and 3-D cultures of Caco-2 cells exhibit similar levels of cell death in response to 
CVB infection 
Enteroviruses primarily egress by direct cell death mediated-lysis of the host cell membrane. 
Because the release of CVB from polarized IECs is dependent on CVB-induced necrotic cell death 
(153), we analyzed cell cytotoxicity to determine if the difference in CVB release between 2-D 
and 3-D cultures resulted from differences in cell death.  To do this, we first measured the levels 
of released lactate dehydrogenase (LDH) in the supernatants of CVB-infected 2-D and 3-D Caco-
2 cultures and found that the levels were comparable between cell culture conditions (Figure 7A). 
In addition, we measured the levels of high-mobility group box 1 (HMGB1), which is released 
into the cell culture supernatants of cells undergoing necrosis (261), in the supernatants of infected 
cultures given that Caco-2 cells primarily undergo necrosis in response to CVB infection (153) 
and found near-equivalent levels of HMGB1 released from both 2-D and 3-D culture conditions 
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(Figure 7B). Finally, we found that both CVB-infected 2-D and 3-D cultures exhibited significant 
morphologic changes as assessed by SEM (Figure 7C, right panel), such as cell rounding and the 
appearance of membrane lesions characteristic of necrosis (Figure 7C). Collectively, these data 
suggest that the increased extracellular CVB titers in 3-D Caco-2 cultures did not result from any 
differences in cell death or cytotoxicity.  
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Figure 7. (A), Levels of released LDH in 2-D or 3-D cultures if Caco-2 cells infected with CVB (1 PFU/cell) for the 
indicated hours post-infection. (B), Levels of HMGB1 (ng/ml) in the supernatants of 2-D or 3-D Caco-2 cultures 
infected with CVB (1 PFU/cell) for the indicated hours.  (C), Scanning electron micrographs of 2-D (top) or 3-D 
(bottom) cultures of Caco-2 cells. Shown are mock infected controls (at left) and cultures infected with CVB for 24 
hrs (middle and right). At right, zoomed images of single infected cells with black arrows denoting membrane lesions.  
In (A) and (B), ns (not significant) as determined by a Student’s t-test. 
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2.3.6 Transcriptional profiling between CVB-infected 2-D and 3-D Caco-2 cultures by 
RNASeq 
We next profiled transcriptional changes between 2-D and 3-D Caco-2 cells infected with CVB to 
determine if alterations in gene expression could account for the differences in CVB release 
between the culture conditions. To do this, we utilized RNASeq followed by DESeq2 analysis to 
identify genes differentially expressed between mock- and CVB-infected cultures. We observed 
significant changes in gene expression upon CVB-infection of either 2-D or 3-D Caco-2 cultures 
(Figure 8A, Supplemental Datasets 2 and 3).  CVB infection induced significant (p<0.01) changes 
in the expression of 140 transcripts in 2-D cultures and 311 transcripts in 3-D cultures (Figure 8B). 
In 2-D, there were 58 genes upregulated in response to CVB infection and 82 genes downregulated 
(Figure 8B). In contrast, the vast number of genes differentially expressed in CVB-infected 3-D 
cultures were downregulated (295 of 311 total genes) (Figure 8B). Interestingly, of the transcripts 
differentially expressed in CVB-infected 2-D and 3-D cultures, only 8 were common to both cell 
cultures conditions (Figure 8C). These included induced genes such as the chemokines CCL20 
and CXCL3, the arrestin family member arrestin domain-containing 3 (ARRDC3), nerve growth 
factor receptor (NGFR), and endothelin 1 (EDN1) (Figure 8C). Only a single gene, 
BCL2/Adenovirus E1B 19kDa Interacting Protein 3-Like (BNIP3L)/NIX, which is a pro-apoptotic 
mitochondrial localized homolog of NIP3 (262), was downregulated in both CVB-infected 2-D 
and 3-D cultures (Figure 8D).  
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Figure 8. (A), Hierarchical clustering heat map of genes differentially expressed (p<0.05) in CVB-infected 2-D (at 
left) or 3-D (at right) cultures as determined by RNASeq followed by DeSeq2 analysis. Shown are two independent 
mock-infected 2-D or 3-D cultures and a single CVB infected culture. (B), Heat map of genes upregulated by CVB 
infection in both 2-D and 3-D cultures. (C, D), Heat map of genes differentially upregulated by CVB infection in 2-D 
(C) or 3-D (D) cultures.  In all, the color intensity in indicates the level of gene expression (yellow for up-regulation 
and blue for down-regulation), and grey indicates that no RNAseq reads were detected for that transcript in that sample 
 
The majority of genes differentially induced/suppressed in response to CVB infection were 
unique to 2-D or 3-D cultures. In 2-D infected cells, this included the induction of specific genes 
such as YIP1 family member 7 (YIPF7), a member of the YIP family of Golgi complex-localized 
components (263) that have been associated with intestinal inflammation (264) and the TNFα-
inducible Ankyrin Repeat Domain 1 (ANKRD1), amongst others (Figure 8E, Supplemental 
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Dataset 2). Pathway analysis of genes differentially expressed in CVB-infected 2-D cultures 
revealed an enrichment in NF-κB activation pathways (p=4.02e-8), immune response to Tumor 
necrosis factor receptor 2 (TNF-R2) signaling pathways (p=1.62e-8), and anti-apoptosis and 
survival signaling (p=3.13e-4) (Supplemental Dataset 4). In 3-D CVB-infected cultures, unique 
differentially induced genes included the secreted Wnt antagonist Dickkopf-1 (DKK1), which 
positively regulates proliferation of the intestinal epithelium whose expression thus correlates with 
decreased cell proliferation and differentiation (265) and the transcriptional regulators Early 
Growth Response 1 (EGR1) and T-Box Protein 2 (TBX2) (Figure 8F, Supplemental Dataset 3), 
amongst others. Pathway analysis of genes differentially expressed in CVB-infected 3-D cultures 
revealed an enrichment in the WNT signaling pathway (p=6.09e-3), differentiation of gastric 
mucosa (p=2.36e-3), and immune response C3a signaling (p=4.61e-3) Supplemental Dataset 5).   
2.3.7 CVB infection in 3-D cultures of HeLa cells and PV infection in 3-D Caco-2 cultures 
Because we observed differences in CVB infection between 2-D and 3-D cultures of Caco-2 cells, 
we next assessed whether these differences would occur in 3-D cultures of other cell types, such 
as HeLa cells. Whereas our results in 3-D Caco-2 cultures pointed to an enhanced release of CVB 
from these cultures, we found that CVB infection, as assessed by intracellular and extracellular 
titers in 2-D and 3-D HeLa cells, were near equivalent between both culture conditions (Figure 
9A). In addition, we found that whereas 3-D cultures of Caco-2 cells released more infectious 
compared to 2-D cultures, cells cultured in 3-D became more resistant to infection by PV. 
Importantly, this was not the result of alterations in the expression of PVR, which were not 
significantly different between 2-D and 3-D cultures (Supplemental Figure 1). Taken together, 
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these data point to the cell type- and virus type-specific nature of the release of more infectious 
virus from 3-D Caco-2 cultures.  
 
 
 
Figure 9. (A), CVB titers (pfu/mL) of virus collected from the medium of 2-D or 3-D cultures of HeLa cells infected 
with CVB (1 PFU/cell) for the indicated hours post-infection. (B), PV titers (pfu/mL) of virus collected from the 
medium of 2-D or 3-D cultures of Caco-2 cells infected with PV (3 PFU/cell) for the indicated hours post-infection. 
Data are shown as mean ± standard deviation and are averaged from three independent STLVs, *p<0.05, ns (not 
significant) as determined by a Student’s t-test. 
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2.4 DISCUSSION 
Here, we describe the development of a 3-D-based culture system using Caco-2 cells that can be 
applied to the study of enterovirus infection of human IECs. We show that Caco-2 cells cultured 
in the RWV bioreactor development morphologic and transcriptional phenotypes more similar to 
the GI epithelium in vivo. In addition, we show that these cells can be infected by CVB and release 
more infectious virus than 2-D cells at early stages of the viral life cycle.  
Much of what we know regarding the interactions between CVB and polarized IECs has 
been generated using cell lines, such as Caco-2 cells, under standard 2-D culture conditions. While 
these studies have provided important insights into aspects of CVB infection of polarized IECs, 
they are inherently limited by the significant differences that exist between cell culture and in vivo 
systems. Although the 3-D system we describe here develops phenotypes resembling the GI 
epithelium in vivo, it is not an absolute model of the GI tract in vivo, which has the added 
complexity of other cell types, including immune components as well as a bacterial microbiome 
that undoubtedly influences a variety of aspects of viral pathogenesis. Indeed, previous studies of 
oral PV infections in human PVR transgenic mice lacking expression of the IFNα/β receptor 
suggest that the microbiome facilitates PV infection of the GI epithelium (266, 267). However, 
given the need to ablate the type I IFN system to allow for oral infection in mice, and the fact that 
humans are the primary hosts for enteroviruses, the development of human-based systems to better 
model enterovirus-IEC interactions are critical. Thus, the system we describe here provides a 
platform by which to study CVB, and other enterovirus, infection of the GI epithelium and is likely 
to provide insights into the dialogue that exists between the virus and IECs. Because this system 
is cell-line based, it also has the advantage of being more easily manipulated genetically than other 
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models (such as small animals) and can thus be utilized for gene depletion and/or knockdown 
studies by techniques such as RNAi or CRISPR-Cas9 based approaches.   
A central question that has remain unanswered in the field of CVB-polarized IEC 
interactions is the mechanism by which the virus attaches to DAF on the complex differentiated 
apical surface of IECs and circumnavigates this barrier to reach CAR in the TJ. Given that studies 
of CVB entry into polarized IECs have been restricted to 2-D culture conditions (147, 148), which 
exhibit a less complex apical surface than their 3-D cell counterparts, these questions are inherently 
more difficult to fully address. Our work presented here suggests that CVB is adept at entering the 
GI epithelium rapidly, as we found that entry occurred with similar kinetics between 2-D and 3-D 
cultured cells, despite the complex nature of the apical surface of Caco-2 cells cultured in 3-D. In 
contrast, our studies suggest that PV is either less efficient at entering IECs, or that viral replication 
is less efficient in 3-D, given that we observed a significant reduction in PV titers in Caco-2 cells 
cultured in 3-D. In the case of both CVB and PV, receptor expression in 2-D and 3-D cultures are 
near-equivalent (Supplemental Figure 1), thus the differences in viral infection between 2-D and 
3-D cells cannot be due to receptor expression alone, although receptor localization may certainly 
play a role.  
Despite producing lower levels of vRNA and newly synthesized viral proteins, and 
generating near equivalent intracellular CVB titers, we found that 3-D cultures of Caco-2 cells 
released more infectious virus than did cells cultured in 2-D at early stages of the viral life cycle. 
As we did not detect any differences in CVB-induced cell death or membrane destruction between 
2-D and 3-D cultures, it is difficult to reconcile how 3-D cultures are more efficient at viral release. 
Although cell death and enhanced membrane leakage is likely to be the primary mechanism of 
enteroviral egress, two additional mechanisms recently proposed suggest that enteroviruses can 
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also be released in cell-derived microvesicles (268) and/or by a non-lytic release mechanism (269). 
While we cannot exclude that some amount of released CVB in 3-D Caco-2 cultures resides in 
microvesicles, we found that >99% of the viral activity of CVB-infected supernatants of 2-D and 
3-D cultures could be inhibited by an anti-CVB neutralizing antibody (Supplemental Figure 2). 
However, previous work on vesicle-associated hepatitis A virus (HAV) showed that some 
antibodies neutralize this form of the virus post-entry (270), although the mechanism by which 
this occurs remains unclear.  
The non-lytic release of PV has been proposed to occur via a process facilitated by 
autophagy (269), which is also associated with the formation of enterovirus-induced replication 
organelles (271). Similar to other GI-derived cancer cell lines, Caco-2 cells exhibit high rates of 
resting autophagy (272, 273), which are reduced upon differentiation (274). In the normal GI 
epithelium in vivo, autophagy is also active and is upregulated in proliferating and progenitor cells 
(274). Given the high degree of association between autophagy and the GI epithelium, it is possible 
that the enhanced release of CVB from infected 3-D Caco-2 cells is facilitated by alterations in the 
rate of autophagy in select subpopulations of cells, and thus the enhanced release of viral particles 
by a non-lytic mechanism. Thus, it is possible that the enhanced titers of released CVB early in 
infection in 3-D cultures may be the result of several parallel pathways, which might include non-
lytic release in either microvesicles or by an autophagy-mediated pathway.  
Collectively, our studies show that Caco-2 cells grown in the RWV bioreactor may provide 
a cell culture model that structurally and transcriptionally represents tissue of the human GI tract 
and provides a tool to improve our understanding of enterovirus-host interactions in polarized 
IECs.  
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3.0  ENTEROVIRUSES INFECT HUMAN ENTEROIDS AND INDUCE ANTIVIRAL 
SIGNALING IN A CELL-LINEAGE SPECIFIC MANNER 
Enteroviruses are amongst the most common viral infectious agents of humans and are primarily 
transmitted by the fecal-oral route. However, the events associated with enterovirus infections of 
the human gastrointestinal tract remain largely unknown. Here, we utilized stem cell-derived 
enteroids from human small intestines to study enterovirus infections of the intestinal epithelium. 
We found that enteroids were susceptible to infection by diverse enteroviruses, including echovirus 
11 (E11), coxsackievirus B (CVB), and enterovirus 71 (EV71) and that contrary to an 
immortalized intestinal cell line, enteroids induced antiviral and inflammatory signaling pathways 
in response to infection in a virus-specific manner. Furthermore, utilizing the Notch inhibitor 
dibenzazepine (DBZ) to drive cellular differentiation into secretory cell lineages, we show that 
while goblet cells resist E11 infection, enteroendocrine cells are permissive, suggesting that 
enteroviruses infect specific cell populations in the human intestine. Taken together, our studies 
provide insights into enterovirus infections of the human intestine, which could lead to the 
identification of novel therapeutic targets 
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3.1 INTRODUCTION 
Enteroviruses are significant sources of human infections worldwide and are primarily transmitted 
by the fecal-oral route. Non-poliovirus enteroviruses include coxsackievirus, echovirus, EV71, and 
enterovirus D68 (EV-D68), and are small (~30nm) single stranded RNA viruses belonging to the 
Picornaviridae family. In most cases, enterovirus infections remain asymptomatic, whereas in 
others, infection is associated with symptoms that can range from mild flu-like symptoms to much 
more severe outcomes such as type I diabetes, encephalomyelitis, encephalitis, myocarditis, dilated 
cardiomyopathy, pleurodynia, acute flaccid paralysis, or even death.  
The human gastrointestinal (GI) tract is a complex organ, with an epithelial surface that 
must provide a protective and immunological barrier in a complex and diverse microbial 
environment. The epithelium of the small intestine contains at least seven distinct cell sub-types 
that are responsible for the critical physiological functions of the intestine, including nutrient 
absorption and defense against pathogens. The lack of models that recapitulate the complexity of 
the GI tract has hindered studies into many of the most relevant aspects of enterovirus infection in 
this specialized environment. Although murine models have been developed for the study of 
enterovirus-induced disease (172, 240-242), many of these models require intraperitoneal 
infection, thereby bypassing the GI tract. Moreover, models that recapitulate oral infection often 
require ablation of the host innate immune system (174, 176). Combined with the need to resolve 
any differences that may exist between murine and human infection, there remains an urgent need 
to develop human-based platforms that can provide a more physiologically relevant system by 
which to model enterovirus infections of the GI tract. 
The full repertoire of mature cells in the small intestine in vivo includes those of absorptive 
(enterocytes) and secretory (Paneth, goblet, and enteroendocrine) lineages, which are derived from 
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Lgr5+ stem cells located at the base of intestinal crypts. Despite serving as the primary portal for 
enterovirus entry into the human host, it remains unknown whether enteroviruses target select cell 
types within the intestine for their initial replication. An ex vivo model of the human intestinal 
epithelium has been developed, whereby primary intestinal crypts are isolated and cultured into 
epithelial structures that have been described as “mini-guts”, often termed enteroids (275-277). 
Primary intestinal crypts are plated onto Matrigel, mimicking the enriched levels of laminin α1 
and α2 present at crypt bases in vivo (223) and are cultured in the presence of growth factors that 
induce crucial developmental signaling through the Wnt and Notch pathways. Lgr5+ intestinal 
crypt stem cells differentiate into the various epithelial cell sub-types found in the human small 
intestine in vivo, resulting in the production of enteroid structures over four to five days (214). 
Others have shown that human enteroids can serve as models for the study of enteric infections by 
human rotavirus (232, 278, 279) and norovirus (233). 
In this report, we cultured Lgr5+ stem cell-derived enteroids from human fetal small 
intestines and applied this model to the study of enterovirus infections. We found that human 
enteroids were susceptible to infection by CVB, E11, and EV71 to varying degrees and induced 
potent antiviral signaling pathways in response to viral infections in a virus-specific manner. 
Utilizing the Notch inhibitor dibenzazepine (DBZ) to enrich enteroids with cells of secretory 
lineages, we also show that E11 is unable to replicate in MUC2-positive goblet cells. Collectively, 
these data provide insights into the intestinal cell populations targeted by enteroviruses and point 
to virus-specific pathways induced by these cells in response to infection.    
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3.2 MATERIALS AND METHODS 
Cell culture and human enteroid culturing 
Human Caco-2 colon epithelial cells (ATCC clone HTB-37) were grown in modified Eagle’s 
medium containing 10% fetal bovine serum, nonessential amino acids, sodium pyruvate, and 
penicillin-streptomycin. Human fetal intestinal crypts were isolated and cultured using the protocol 
originally established in (223) with slight modifications for human tissue (280). Human fetal tissue 
from less than 24 weeks gestation was obtained from the University of Pittsburgh Health Sciences 
Tissue Bank via an honest broker system after approval from the University of Pittsburgh 
Institutional Review Board and in accordance with the University of Pittsburgh anatomical tissue 
procurement guidelines. Approximately 100 isolated crypts were plated in each well of a 48-well 
plates onto a thin layer of Matrigel (Corning) and were grown in crypt culture media comprised of 
Advanced DMEM/F12 (Invitrogen) with 20% Hyclone ES Screened Fetal Bovine Serum (Fisher), 
1% Penicillin/Streptomycin (Invitrogen), 1% L-glutamine, Gentamycin, 0.2% Amphotericin B, 
1% N-acetylcysteine (100mM, Sigma), 1% N-2 supplement (100X, Invitrogen), 2% B27 
supplement (50x, Invitrogen), Gibco® HEPES (N-2-hydroxyethylpiperazine-N-2-ethane sulfonic 
acid, 0.05mM, Invitrogen), ROCK Inhibitor Y-27632 (1mM, 100x, Sigma) with the following 
growth factors 100 ng/ml WNT3a (Fisher), 500 ng/ml R-spondin (R&D), 100 ng/ml Noggin 
(Peprotech) and 50 ng/ml EGF (Fisher) (226, 280) for the remainder of the respective experiments, 
with media changes occurring every 48 hours. For image-based applications, enteroids were plated 
onto Matrigel in 8-well chamber slides (Nuc LabTek-II). In some cases, 10 μM dibenzazepine 
DBZ (Sigma 209984-56-5) or 0.1% DMSO vehicle control were added to growing cultures 48 
hours post-plating, and were replaced every subsequent 48 hours, as indicated.  
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Viral infections  
Experiments were performed with CVB3 (RD), EV71 (GDV083), or E11 (Gregory) that were 
expanded as described previously (281). For enteroid infections, wells (containing ~100 enteroids) 
were infected with 10^6 PFU of the indicated virus. In parallel, wells containing Caco-2 cells 
2*10^5) were also infected with 10^6 PFU virus. Samples were collected 24 hours post-infection 
unless otherwise indicated. TCID50 assays were performed in 96 well plates of confluent Caco-2 
cells (ATCC clone HTB-37), using 5-fold serial dilutions of supernatant collected from E11-
infected enteroid cultures, with at least three technical replicates per biological sample. 
 
qPCR and cDNA synthesis 
Total RNA was prepared from enteroids or Caco-2 cells using the Sigma GenElute total 
mammalian RNA miniprep kit, according to the protocol of the manufacturer and using the 
supplementary Sigma DNase digest reagent. RNA was reverse transcribed with the iScript cDNA 
synthesis kit (Bio-Rad), following the manufacturer’s instructions. 1 μg of total RNA was reversed 
transcribed in a 20 μL reaction, and subsequently diluted to 100 μL for use. RT-qPCR was 
performed using the iQ SYBR Green Supermix (Bio-Rad) on a CFX96 Touch Real-Time PCR 
Detection System (Bio-Rad). Gene expression was determined based on a ΔCQ method (CQ is the 
Bio-Rad standard for cycle at point of quantification), normalized to the sample’s CQ for human 
actin. Primer sequences for actin, Muc17, NAALADL1, CVB, E11, and EV71 have been 
previously described (281, 282). Additional primer sequences used in the study are located in 
Supplemental Table 1.  
 
 
 73 
RNASeq 
Total RNA was extracted from enteroids using the GenElute mammalian total RNA miniprep kit (Sigma) 
as described in the manufacturer’s protocol, including DNase (Sigma) treatment. RNA quality was assessed 
by NanoDrop and an Agilent bioanalyzer and 1,000 ng was used for library preparation using the TruSeq 
Stranded mRNA Library Preparation kit (Illumina) per the manufacturer’s instructions. Sequencing was 
performed on the Illumina Nextseq 500. RNAseq FASTQ data were processed and mapped to the human 
reference genome (hg19) using CLC Genomics Workbench 9 (Qiagen). The Deseq2 package in R (250) 
was used to determine differentially expressed genes at a significance cutoff of p<0.01. Hierarchical gene 
expression clustering was performed using Cluster 3.0, using average linkage clustering of genes centered 
by their mean RPKM values. Heat maps (based on lop(RPKM) values) were generated using Treeview or 
MeV software. Pathway analysis was performed using Gene Set Enrichment Analysis(283), with statistical 
significance determined based on the family wise-error rate P-values as stated. Analysis of the 
transcriptional profile of Caco-2 cells were based on previously published RNASeq datasets (282) and 
which were deposited in sequence read archives (SRA) SRP065330. Files from RNASeq from enteroid 
preparations used in this study were deposited in SRA, accession SRP091501. 
 
Immunofluorescence microscopy 
Cell monolayers or enteroids were washed with PBS and fixed with 4% paraformaldehyde at room 
temperature, followed by 0.25% Triton X-100 to permeabilize cell membranes. Enteroids were 
incubated with primary antibodies for 1 hour at room temperature, washed, and then incubated 
with 30 minutes at room temperature with Alexa-Fluor-conjugated secondary antibodies 
(Invitrogen). Slides were washed and mounted with Vectashield (Vector Laboratories) containing 
4′,6-diamidino-2-phenylindole (DAPI). The following antibodies or reagents were used—
recombinant anti-dsRNA antibody (provided by Abraham Brass, University of Massachusetts and 
described previously (284)), E-cadherin (Invitrogen), Chromogranin A (Invitrogen), ZO-1 
 74 
(Invitrogen), Cytokeratin-19 (Abcam), and Alexa Fluor 594 or 633 conjugated Phalloidin 
(Invitrogen). Images were captured using an Olympus FV1000 laser scanning confocal microscope 
and contrast adjusted in Photoshop. Image analysis was performed using Fiji. Mucin-2 positive 
cells were manually counted using the ImageJ Cell Counter plugin. 
 
Statistics 
All statistical analysis was performed using GraphPad Prism. Experiments were performed at least 
three times from independent enteroids preparations as indicated in the figure legends or as 
detailed. Data are presented as mean ± standard deviation. Except were specified, a Student’s t- 
test was used to determine statistical significance. Specific p-values are detailed in the figure 
legends.   
3.3 RESULTS 
3.3.1 Human enteroids recapitulate the multicellular complexity of the human small 
intestine epithelium 
To model the earliest events associated with enterovirus transmission in the human intestine, we 
sought to develop a primary human-based model that recapitulates the multi-cellular complexity 
of the GI epithelium, including the differentiation of discrete lineages of absorptive and secretory 
cells as well as the topography of self-organizing intestinal crypts and villi. To do this, we 
generated primary human intestinal-derived enteroid cultures derived from human fetal intestinal 
crypts containing Lgr5+ stem cells (schematic, Figure 10A). Following a culturing period of five 
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days in the presence of growth factors (Wnt3a, Noggin, R-spondin, and epidermal growth factor 
(EGF)), intestinal stem cells proliferate and differentiate, budding into enteroids containing villus-
like structures, whilst signaling molecules from differentiated daughter cells help maintain the 
stem cell niche (86) (schematic, Figure 10A). After three to five days of culture, we observed the 
development of large formations of cells budding from the expanding crypts (Figure 10A, right).  
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Figure 10. (A) Illustration depicting the strategy for enteroid culturing. Crypts are isolated from whole intestine 
epithelia and grown in media containing Wnt3a, Noggin, EGF, and R-spondin for five days to induce proliferation 
and differentiation. At right, brightfield image of enteroids after five days in culture. (B, C) Human epithelial derived 
enteroids were immunostained for the goblet cell marker MUC2 (green) and actin (red) (B) or the enterocyte markers 
E-cadherin (red, left) or, the enteroendocrine marker chromogranin A (CHGA, green, right) and the Paneth cell marker 
Lysozyme C (red, right) (C). (D) Hierarchical clustering heat map of differential gene expression profiles (based on 
log (RPKM) values) between two independent preparations of Caco-2 cells and three independent human enteroid 
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cultures by RNAseq. (E) Heatmap (based on log (RPKM) values) comparing gene expression levels between Caco-2 
and enteroid cultures for markers of differentiatied small intestinal epithelial cell types; enterocytes (CDX1, SI), goblet 
cells (MUC2), Paneth cells, (Reg3a, DefA5, DefA6), and M-cells (SPIB, GP2). (F) RT-qPCR comparison of 
expression levels for intestinal genes in Caco-2 cells and human enteroid cultures. Data in (F) are shown as mean ± 
standard deviation and are normalized to Caco-2 cells (***p<0.001; **p<0.01). 
 
To assess the development of a multicellular phenotype, enteroids were immunostained for 
MUC2 as a marker of goblet cells, E-cadherin as a marker of enterocytes, lysozyme-C as a marker 
of Paneth cells, and chromogranin A (CHGA) as a marker of enteroendocrine cells, which revealed 
the presence of all cell types (Figure 10B, 10C). To profile the transcriptional differences between 
human enteroids and Caco-2 cells, an immortalized colorectal cell line commonly used in 
enterovirus research (147, 148, 153, 158, 282), we utilized RNASeq. Not surprisingly, the 
transcriptional profiles of primary enteroids were distinct from Caco-2 cells, and clustered 
accordingly (Figure 10D). Consistent with the development of a multicellular phenotype, enteroids 
expressed a number of biomarkers for several differentiated epithelial cell types including CDX1 
and sucrase-isomaltase, both enterocyte markers, as well as the M-cell marker SPIB and the stem 
cell marker OLFM4 (Figure 10E). Furthermore, the expression of secretory cell markers were 
enriched in enteroids when compared to Caco-2 cells, including MUC2 and the genes of Paneth 
cell antimicrobial products Reg3a and alpha defensins 5 and 6 as well as the transcription factors 
GFI1 and INSM1, and the enteroendocrine cell marker Neurog3 (Figure 10E). Significantly 
enhanced expression of MUC2 and MUC17, as well as the small intestine marker N-Acetylated 
Alpha-Linked Acidic Dipeptidase-Like 1 (NAALADL1), in enteroids was confirmed by RT-qPCR 
(Figure 10F). Taken together, these data demonstrate that primary human fetal enteroid cultures 
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contain differentiated epithelial cells of multiple lineages associated with the diverse functions of 
the intestinal barrier including absorption, glycocalyx production, and antimicrobial defenses. 
3.3.2 Human enteroids are susceptible to enterovirus infection 
We next assessed whether human enteroids were susceptible to enterovirus infections and 
compared their level of infection to Caco-2 cells, which are highly permissive to infection (147, 
158, 282). Using immunofluorescence microscopy for double stranded viral RNA (vRNA), which 
is formed as a replication intermediate, we found that CVB, E11, and EV71 all replicated in human 
enteroids by 24hrs post-infection (p.i.), although the level of infection by EV71 was consistently 
lower than that of either CVB or E11 (Figure 11A). Infected cells were positive for the epithelial 
intermediate filament cytokeratin-19 (Supplemental Figure 3A). To confirm our infection results, 
we performed RT-qPCR for vRNA from several enteroid preparations and compared these levels 
to those in Caco-2 cells. Consistent with our immunofluorescence data, we found that enteroids 
were robustly infected with CVB and E11, with slightly lower efficiency than in Caco-2 cells, but 
that EV71 replicated to lower levels in enteroids (Figure 11B).  
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Figure 11. (A) Enteroids infected with CVB, E11, or EV71 for 24 hours, or mock-infected controls, were 
immunostained for viral RNA (in green) using an antibody against dsRNA. DAPI-stained nuclei are shown in blue. 
(B) RT-qPCR for CVB, E11, or EV71 vRNA from Caco-2 cells (grey) or three independent enteroid preparations 
-infected 
of enteroid compared to a mock infected control. Images are merged composites of differential interference contrast 
(DIC), DAPI-stained nuclei (in blue) and vRNA (in red).. Right, confocal micrographs of mock- or E11-infected 
enteroids immunostained for vRNA (green) and occludin (red) 24hrs following infection. Zoomed image of the white 
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box shown in middle at right. (D) Immunofluorescent staining for viral dsRNA (red, vRNA) and DAPI-stained nuclei 
over a time course of E11 infection in enteroids ranging from early (8 hour) to advanced (24 hour) stages of infection. 
(E) E11 RNA levels as determined by RT-qPCR throughout a time course of infection (at the indicated hrs p.i.) in an 
enteroid culture. (F) E11 titers (shown as PFU per milliliter) in supernatants of Caco-2 or enteroid cultures 24 hours 
post infection. Data in (B, E-F) are shown as mean ± standard deviation and are normalized to vRNA levels at 4hr 
post-infection (E) (***p<0.001; **p<0.01; *p<0.05). 
 
In addition, we found that enterovirus infection elicited pronounced cytotoxicity, which 
was associated with loss of crypt morphology and integrity within 24hrs p.i. (Figure 11C, left 
panels) and the mislocalization of the tight junction protein occludin, which we have shown 
previously is disrupted by enterovirus infection (24) (Figure 11C, right panels). Consistent with 
the induction of cell death, we also observed increased levels of released HMGB1, which is 
associated with cell necrosis, in medium collected from E11, but not CVB or EV71, infected 
enteroids (Supplemental Figure 3B). To determine the kinetics of E11 replication, we utilized 
immunofluorescence and RT-qPCR for vRNA and found that viral dsRNA was generated within 
8hrs post-infection (p.i.), with levels increasing until 24hrs p.i. (Figure 11D), which was confirmed 
by RT-qPCR for total vRNA (Figure 11E). Finally, we verified that enteroids produced infectious 
virus by measuring infectious viral titers and found that in six independent enteroid preparations, 
E11 titers were similar to those produced from infected Caco-2 cells (Figure 11F). These data show 
that human enteroids are permissive to enterovirus infection and are capable of supporting 
replication and progeny release.  
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3.3.3 Echovirus 11, but not CVB, infection of human enteroids induces antiviral signaling 
In cell lines, including Caco-2 cells, enteroviruses robustly attenuate the host innate immune 
system and infection is not accompanied by the induction of significant antiviral signaling (161). 
In contrast, in vivo studies suggest that the innate immune system is at least one bottleneck for 
enteral infection of these viruses as ablation of the innate immune system is often required for oral 
inoculation of mice (174, 176). To assess whether human enteroids respond to enterovirus 
infection by inducing antiviral signaling, we utilized RNASeq in enteroids infected with CVB, 
E11, or EV71. Consistent with our immunofluorescence and RT-qPCR studies, we found that both 
E11 and CVB robustly infected enteroids whereas the level of EV71 infection was significantly 
lower, as assessed by FPKM values (Figure 12A). For consistency, independent enteroid 
preparations (six total) are assigned numerical identifiers to compare infections and transcriptional 
changes in matched preparations. Surprisingly, we found that whereas E11 infection induced the 
differential expression of 350 transcripts, CVB infection only induced changes in 13 transcripts, 
with only one shared transcript between viruses (Figure 12B, Supplemental Figure 4A, 4B).  
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Figure 12. (A) Table of Fragments Per Kilobase of transcript per Million mapped reads (FPKM) values for CVB, 
E11, or EV71 in three (CVB, EV71) or five (E11) independent enteroid preparations as determined by RNASeq. In 
panels (A) and (C), six independent enteroid preparations are assigned numerical identifiers (1-6) to facilitate direct 
comparison of transcript changes between matched preparations. (B) Venn diagram of transcripts induced by E11 or 
CVB infection, with only one transcript shared between viruses.  (C) Heatmap (based on log(RPKM) values) of highly 
upregulated antiviral and pro-inflammatory transcripts in E11-, CVB-, or EV71-infected enteroids compared to mock-
infected enteroids. (D) RT-qPCR for the indicated genes in three additional enteroid preparations (labeled 1-3) infected 
with E11. (E), HERC5 and CXCL11 mRNA levels as determined by RT-qPCR in Caco-2 cells and two independent 
enteroids preparations infected with CVB or E11 (left y-axis). Viral RNA levels are also shown for each sample, 
relative to CVB levels in matched infections (right y-axis). (F) ELISA for CXCL10 (shown as pg/mL) from four 
independent enteroid preparations infected with CVB, E11, or EV71 for 24hrs compared to mock-infected controls. 
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Data in (D-F) are shown as mean ± standard deviation and are normalized to mock-infected controls (D, E left y-axis). 
**p<0.01; ***p<0.001. In (C), grey denotes transcripts with zero mapped reads. 
 
Interestingly, we found that whereas enteroids induced robust type III IFNs (IFNλ1-2), IFN 
stimulated genes (ISGs), chemokines, and cytokines in response to E11 infection, these same 
pathways were not induced by CVB or EV71 infection (Figure 12C). Gene set enrichment analysis 
(GSEA) (283) revealed the enrichment of transcripts associated with NF-κB signaling (false 
discovery rate (FDR)=0) and IFN signaling (FDR=0.02) in E11-infected enteroids (Supplemental 
Figure 5A). The induction of antiviral and inflammatory signaling in E11-infected enteroids was 
confirmed by RT-qPCR in additional enteroid preparations, which all exhibited pronounced 
induction of these pathways in response to infection (Figure 12D, Supplemental Figure 5B). In 
addition, we confirmed that these pathways were induced specifically in E11-infected enteroids, 
and not in Caco-2 cells, or in response to CVB, using RT-qPCR for HERC5 (an interferon (IFN)-
inducible E3 ligase (285)) and CXCL11 (Figure 12E). We also found that enteroids treated with 
the synthetic dsRNA ligand polyinosinic-polycytidylic acid (poly(I:C)) or infected with E11 
induced the expression of an inflammatory mediator, whereas infection with CVB did not, 
suggesting that stimulation of toll-like receptor (TLR3) might be involved in this induction 
(Supplemental Figure 5C). Finally, using an ELISA for CXCL10, we confirmed that the observed 
transcriptional changes correlated with the production of high levels of protein only in E11-
infected enteroids and not in CVB- or EV71-infected enteroids, or in Caco-2 cells (Figure 12F). 
Collectively, these data show that human enteroids respond to E11, but not CVB, infection by 
inducing antiviral signaling pathways, suggesting that these signals are induced in a virus-specific 
manner.   
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3.3.4 Goblet cells are not infected by Echovirus 11 
A major gap in our existing knowledge of enterovirus entry into the human host is whether these 
viruses target the intestinal epithelium in a cell-type specific manner. Although it has been assumed 
that these viruses target enterocytes, it has been suggested that they might bypass the epithelium 
completely by targeting other cell types, such as M-cells (114, 115). The lack of availability of 
models that reflect the multicellular phenotype of the human intestine has thus directly limited our 
ability to address this critical question. We therefore took advantage of the ability of primary 
human enteroids to develop into multiple cell types, such as those of absorptive (enterocytes) and 
secretory (goblet, enteroendocrine, and Paneth) lineages to determine whether enteroviruses target 
specific cell types in the human intestine. By immunofluorescence microscopy, we observed what 
appeared to be the lack of infection of MUC2+ goblet cells in enteroids infected with E11 
(Supplemental Figure 6A).  
Goblet cells are characterized by high levels of cytoplasmic MUC2, which is localized at 
the basal region of the cell body (Supplemental Figure 6B). However, the low abundance of total 
MUC2+ cells in enteroids (~10% of total cells) (Figure 13C), coupled with the lack of infection in 
100% of cells, complicated an assessment of whether MUC2+ cells resisted E11 infection. 
Therefore, we sought to directly manipulate the ratio of cells of absorptive and secretory lineages 
in enteroids and assess whether this impacted viral infection and/or the induction of antiviral 
signaling. The culturing of enteroids produces cells of secretory lineage (goblet and Paneth) 
through the activation of the Wnt signaling pathway using Wnt3a ligand, which is amplified by R-
spondin (277). However, enterocyte differentiation and villus formation are stimulated by EGF 
(277). Previous studies have shown that the ratio of absorptive to secretory cells is further regulated 
by the Notch signaling pathway, whereby Notch ligands such as Dll4 enhance the differentiation 
 85 
of the enterocyte lineage (68, 229, 286). Thus, we utilized the Notch inhibitor dibenzazepine 
(DBZ), which increases the ratio of secretory cells in human intestinal tissue (93) to directly 
enhance the presence of secretory cells in enteroids. To do this, enteroids were grown in the 
presence of DBZ (or DMSO control), beginning 48hrs following the initiation of culturing and 
until the end of analysis (~5-7 days post-culturing) (Figure 13A). We found that DBZ treatment 
induced a dramatic increase in the numbers of MUC2+ cells, with an increase from ~10% to ~50% 
(Figures 13A and 13C). In addition, we also observed a significant enhancement in the numbers 
of CHGA-positive enteroendocrine cells following DBZ treatment (Figures 13B, 13C). Consistent 
with the enhancement in the total numbers of secretory cells, DBZ-treated enteroids exhibited 
significant increases in the expression of goblet (MUC2) and Paneth (Reg3A and DefA6) markers 
and modest decreases in an enterocyte marker (CDX1) compared to DMSO-treated controls as 
assessed by RT-qPCR (Supplemental Figure 6C). As expected, this effect was specific for human 
enteroids as DBZ had no effect on the expression of secretory cell markers in Caco-2 cells 
(Supplemental Figure 6D). To further profile the changes induced by DBZ treatment, we compared 
the transcriptional profiles of DMSO- and DBZ-treated enteroids by RNASeq. These studies 
revealed the upregulation of transcripts associated with enteroendocrine (Neurog3, INSM1, Pax4) 
and cells of secretory lineage (MUC2, GFI1, FOXA2, Reg3A, DefA5-6, and SPINK4) with a 
corresponding downregulation of transcripts associated with M-cells (SPIB), cells of absorptive 
lineage (BEST4), stem cell markers (OLFM4 and LGR5), and the Notch signaling-associated 
factors (HES1) (Figure 13D).  
 
 86 
 
Figure 13. (A and B) Confocal micrographs of enteroids immunostained for MUC2 (green, A) or CHGA (B) to label 
cells of secretory lineage (goblet, enteroendocrine) following treatment with DBZ for 4 days or treatment with DMSO 
vehicle control. DAPI-stained nuclei are in blue. (Scale bars, 50 μm.) (C) Quantification of the number of MUC2- or 
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CHGA-positive cells per enteroid (shown as a percent of total cells as determined by DAPI staining). (D) Heat map 
[based on log(RPKM) values] depicting expression levels for various epithelial subtype markers (as indicated) in 
DMSO- and DBZ-treated enteroid samples as determined by RNA-seq. (E) Confocal micrograph of enteroids infected 
with E11 for 24 hours and then immunostained for CHGA (green) and vRNA (red). (Bottom) Zoomed image of white 
boxed area shown in Top. White arrows denote CHGA- and vRNA-positive cells. (Scale bars, 20 μm.) (F) Confocal 
micrograph of DMSO- or DBZ-treated enteroids immunostained for MUC2 (red) and E11 vRNA (green) 24 hours p.i. 
DAPI-stained nuclei are shown in blue. (Scale bars, 50 μm.) (G, Top) Zoomed images of white boxed areas shown in 
F highlighting the lack of E11 infection in MUC2-positive cells. (Bottom) Quantification of the numbers of MUC2- 
or CHGA-positive cells that exhibited the presence of E11 vRNA. (H) Table of FPKM values from two independent 
enteroid preparations treated with DMSO or DBZ and infected with E11 for 24 hours as indicated. (I) Heat maps 
[based on log(RPKM) values] of differentially expressed genes induced by E11 infection in DMSO- or DBZ-treated 
enteroids. Data in C and G, Bottom are shown as mean ± SD, with each point representing an independent enteroid. 
***P < 0.001. 
 
We next performed immunofluorescence microscopy for vRNA and either CHGA or 
MUC2 in E11-infected enteroids that had been treated with DMSO or DBZ. We observed the 
association between CHGA positive cells and vRNA (Figure 13E, 13G Bottom), but found that 
vRNA was rarely associated with MUC2-positive cells (Figure 13F, 13G), suggesting that E11 is 
unable to replicate in goblet cells. We next determined whether the reduced infection of MUC2+ 
cells resulted from their unique induction of antiviral signaling by performing RNASeq in DMSO- 
or DBZ-treated enteroids infected with E11. FPKM values indicated that DBZ treatment had little 
impact on the total levels of vRNA (Figure 13H). Differential expression analysis revealed that 
although several transcripts were specifically altered by E11 in DBZ-treated enteroids, these 
transcripts were all downregulated with diverse and largely unknown functions (Supplemental 
Figure 6E), suggesting that they were not responsible for the lack of infection in goblet cells. 
Instead, most of the transcripts induced by E11 infection, such as those associated with antiviral 
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or inflammatory signaling, were conserved between DMSO- and DBZ-treated samples (Figure 
13I). Taken together, these data suggest that E11 is unable to replicate in goblet cells and that this 
restriction is unlikely to be the result of transcriptional changes.  
3.4 DISCUSSION 
Here, we used human enteroids to perform the first studies of enterovirus infections in human 
primary-derived intestinal epithelia that contain the full repertoire of differentiated cell types. The 
lack of availability of an accurate system to model enterovirus infections of the intestinal 
epithelium has resulted in a dearth of information regarding the earliest stages of infection, during 
which enteroviruses infect and surpass the intestinal epithelium in order to reach secondary sites 
of infection, where more severe pathologies can ensue. We show that primary human enteroids 
provide an ideal system by which to model enterovirus-GI tract interactions and better recapitulate 
the events associated with virus infections in vivo.  
We show that CVB, E11, and EV71 actively replicate in enteroids, suggesting that these 
viruses initiate their infections in humans by first infecting the epithelium to access underlying 
tissue. However, there were differences in the relative permissiveness of enteroids to enterovirus 
infections, with EV71 infecting enteroids with relatively low efficiency by comparison. It is not 
clear why EV71 failed to infect enteroids to significant levels even when infected with the same 
inoculum as CVB and E11, while Caco-2 cells were readily infected. Based upon transcriptional 
profiling, the levels of SCARB2, a primary receptor for EV71 (287), and other CVB and E11 
receptors, were similar between enteroids and Caco-2 cells (Supplemental Figure 7A). However, 
it is possible that in enteroids this receptor is not accessible to virus given differences in receptor 
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localization between Caco-2 cells and fully differentiated enteroids that have a complex 3-
dimensional structure which may affect viral access to apical surfaces, or that the virus utilizes a 
different receptor for epithelial infections. Both E11 and CVB, for example, bind to the apically 
localized GPI-anchored DAF (49, 236), which facilitates their binding and infection of the fully 
differentiated intestinal surface, as has been shown for CVB in polarized Caco-2 cells (239). 
Alternatively, it is possible that innate immune detection and signaling in enteroids may be more 
effective at controlling EV71 infection, however, we did not detect the induction of any significant 
antiviral signaling pathways in EV71-enteroids by RNASeq, suggesting that the restriction of 
EV71 infection occurs earlier in the viral life cycle.  
In contrast to EV71, we detected the robust induction of antiviral signaling in response to 
E11 infection of enteroids. Interestingly, this induction was specific for E11, as CVB infection did 
not elicit these pathways. Although the level of CVB infection in enteroids was modestly lower 
than that observed with E11, these changes are likely not responsible for the differential induction 
of innate immune pathways given the magnitude of these differences. In cell culture models, 
enteroviruses utilize virally-encoded proteases to cleave essential host signaling molecules to 
diminish antiviral signaling (reviewed in (161)). It is unknown whether E11, or other echoviruses, 
are less efficient at suppressing these pathways, or whether mechanisms of detection differ 
between enteroviruses. However, our data suggest that there may be important differences between 
how the human intestine responds to enteroviral infections in a virus-specific manner, which could 
impact a variety of aspects of viral pathogenesis. Despite the robust induction of antiviral signals, 
E11 robustly replicated in enteroids, with similar efficiency as in Caco-2 cells, which do not induce 
similar antiviral pathways. Thus, despite the induction of potent antiviral signaling pathways in 
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enteroids, E11 is still capable of replicating to high efficiency, suggesting that it has potent 
mechanisms to evade this response.  
Of particular importance, we found that E11 was unable to replicate in goblet cells, but that 
enteroendocrine cells supported replication. Little is known about the susceptibility of various 
intestinal epithelial sub-types to enterovirus infections. Previous studies using M-like cells derived 
by the co-culturing of Caco-2 cells with lymphocytes showed that poliovirus readily adhered to 
the apical surfaces of these cells and was rapidly transcytosed to the basolateral space (within 1-2 
hrs p.i.)36. These findings led to speculation that enteroviruses might bypass the intestinal 
epithelium entirely and would instead transmigrate across the intestinal barrier through non-
infectious trancytosis across M-cells. However, our studies indicate that enteroviruses (including 
poliovirus (Supplemental Figure 7B) robustly infect enteroids, and may specifically target cells of 
specific lineages or subtypes to cross the intestinal barrier. It is unclear why MUC2-expressing 
goblet cells are less permissive to E11 infection, although our RNASeq findings from DBZ-treated 
enteroids do not indicate that unique antiviral innate pathways are induced in MUC2-enriched 
enteroids. Thus, it seems likely that other properties of these cells, such as their ability to secret 
mucins or the presence of mucin-enriched cytoplasmic secretory granules, may limit enterovirus 
replication. 
Taken together, we show that human enteroids can be used to model the multicellular 
environment of the GI epithelium, which serves as a key cellular portal by which enteroviruses 
enter their human hosts. Our findings provide important insights into events associated with the 
earliest stages of enterovirus infection, and demonstrate that human enteroids can be used as 
platforms to define the complex dialogue that exists between enteroviruses and the intestinal 
epithelium, which undoubtedly have profound impacts on enterovirus pathogenesis. 
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4.0  CONCLUSIONS 
Enteroviruses are important human pathogens and the etiological agents of a variety of human 
diseases. Animal models have been developed to study enterovirus disease at some of the sites of 
secondary infection, including the heart and pancreas, however there are no functional animal 
models to study enterovirus infection of the intestinal epithelium, from which the virus must 
disseminate in order to cause more advanced pathologies. Traditional cell cultures of immortalized 
intestinal lines have been used to assess various aspects of the enterovirus life cycle including entry 
and the induction of cell death signaling pathways. But these standard cultures fail to fully 
recapitulate the differentiated, polarized nature of the intestinal epithelium as it exists in vivo. 
Therefore, we have utilized two newly developed cell culturing techniques: cell lines in 3-D 
culture, as well as primary human intestinal crypts that have been allowed to differentiate in 
culture, in order to study fundamental aspects of enterovirus biology in the intestinal epithelium. 
4.1 A 3-D CELL CULTURE MODEL FOR CVB INFECTION 
Chapter 2 details the use of a rotating wall vessel based bioreactor for studying enterovirus 
infection in a 3-D cultured intestinal cell line. We grew Caco-2 cells on collagen-coated beads, for 
21 days, in a constantly rotating vessel. At the end of the culturing period, we assessed the cells 
[Grab your reader’s attention with a great quote from the document or use this 
space to emphasize a key point. To place this text box anywhere on the page, just drag it.] 
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for signs of polarization. As shown by immunofluorescent staining of various markers, 3-D Caco-
2 cultures have properly formed tight and adherens junctions. Unlike control Caco-2 cells that 
were grown in traditional “2-D” cultures, the apical surfaces of these 3-D grown cells have dense 
brush borders of microvilli on their apical surfaces, which we demonstrated by staining as well as 
scanning electron microscopy. RNASeq and qPCR analysis revealed that various genes related to 
intestinal processes, such as nutrient uptake and glycocalyx production (characteristics of 
enterocyte and goblet cells, respectively), are highly upregulated in 3-D cells. We show that 3-D 
Caco-2 cells can be infected with CVB and PV. CVB infection occurs in a DAF-dependent manner 
and with similar entry kinetics as in 2-D Caco-2 cells. However, CVB replicates at slightly slower 
rates in 3-D cells, as determined by levels of the viral genome as well as viral capsid protein VP1. 
Despite this, we found that levels of released progeny virus are consistently significantly higher in 
3-D infected cultures compared to 2-D, suggesting that viral release occurs with greater efficiency 
in these cells.  
These findings confirm that the slow turning vessel bioreactor can be used to grow 
intestinal cell lines in 3-D. These cells possess in vivo-like properties that are absent in cells grown 
under standard culturing techniques and are permissive to enterovirus infection. The mechanisms 
underlying the different kinetics of viral release in 3-D and 2-D cells have yet to be resolved. A 
release process, termed AWOL (autophagy-mediated exit without lysis), has been well 
characterized for poliovirus (269, 288, 289). By this mechanism, PV is shed in autophagy-derived 
microvesicles from cells without inducing cell death. Another picornavirus, hepatitis A virus, can 
be found in extracellular vesicles that resemble exosomes, sometimes with multiple virions per 
vesicle (270). There has been recent research that suggests CVB may also be associated with 
extracellular vesicles in some circumstances (268, 290). It is tempting to suggest that some of the 
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increased viral titer in 3-D Caco-2 cultures could be due to release occurring over a longer duration 
in a subpopulation of cells that are not undergoing lysis, potentially further enhanced by the greatly 
extended apical surface area on 3-D cells that are dense with microvilli. However, our preliminary 
findings based on microvesicle purification have shown that the enhanced release titers are likely 
not due to CVB in exosomes or autophagic vesicles (data not shown). This is consistent with our 
results concerning cell death upon infection of 3-D cultures, as necrosis occurs at similar levels 
and timing in 3-D and 2-D (Figure 7). Interestingly, PV is released at lower titers in 3-D Caco-2 
cells compared to 2-D, indicating that there may be additional enterovirus-specific properties of 3-
D cells that affect release. Further research will be required to determine the mechanisms of these 
and other observations of enterovirus infection of 3-D intestinal cell lines. 
4.2 E11 INFECTS ENTEROIDS IN A CELL LINEAGE-DEPENDENT MANNER 
In chapter 3, we describe a culture system that is derived from primary human intestinal crypts 
that are grown ex vivo. The isolated crypts contain Lgr5+ intestinal stem cells which, when grown 
in the presence of Wnt and other signaling ligands, expand into o termed “enteroids”, containing 
villus and crypt-like structures. Over the course of five days, cells differentiate into distinct 
epithelial sub cell-types including enterocyte, Paneth, and goblet cells. We show, by staining and 
RNASeq, that markers of differentiation for these cell types exist in our cultures. We found that 
enteroid cultures are highly permissive to E11 and can be infected by CVB as well, though less 
efficiently. EV71, however, fails to infect our cultures even at a high multiplicity of infection. 
Others have reported that the colorectal adenocarcinoma line HT29 can be infected by EV71, 
resulting in an IFN response and high levels of pro-inflammatory cytokines (167). This strong 
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antiviral response does not occur in non-polarized HeLa cells (166), likely owing to more robust 
cleavage of IFN signaling adapter TRIF by viral protein 3Cpro as described in section 1.3.1 (291). 
It is not clear what factors are responsible for poor EV71 infectivity in enteroids. It could be due 
to the structure and physiology of the enteroids or differences in which cell types are present, levels 
of gene expression, or cell signaling. 
It is currently unknown, in the field of picornavirus biology, whether enteroviruses target 
specific cell types in the small intestine. We have shown that E11 infects the majority of cells in 
enteroid cultures, which contain a wide repertoire of cell lineages including enterocytes and 
enteroendocrine cells. However, MUC2+ goblet cells are resistant to E11. In contrast, 
enteroendocrine cells, a sub-lineage of intestinal secretory cells that are responsible for hormone 
and neurotransmitter secretion, are permissive to E11. Interestingly, Saxena et al. used a similar 
enteroid model to show that rotavirus also infects enterocytes and enteroendocrine, but not goblet 
cells (232). 
Interestingly, enteroids, but not Caco-2 cells, elicit strong antiviral signaling in response to 
E11 infection, through the interferon and NF-κB pathways. CVB fails to induce the same levels of 
interferon-stimulated gene expression in enteroids. The mechanism for this disparity is currently 
unknown. This may be, in part, due to a difference in levels of infection between the two viruses. 
For each individual enteroid preparation, derived from a unique primary tissue sample, E11 
infected to higher FPKM levels, as determined by RNAseq (Figure 12A). CVB FPKM levels are 
relatively high in enteroid samples 1 and 3. This demonstrates that infection has occurred, despite 
failing to induce antiviral signaling (Figure 12C) and resulting in differential expression levels 
very few genes in total (Figure 12B).  
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Further studies will be required to determine if E11 is less adept at silencing innate immune 
signaling compared to CVB. Though relatively little is known about the molecular mechanisms 
specific to E11 infection, CVB’s ability to shut down host signaling responses, via cleavage of 
host proteins such as eIF4G, MAVS, and TRIF is well characterized. If E11 proteases do not target 
these substrates, or cleave signaling molecules with different kinetics, it may explain the enhanced 
signaling response of E11 in enteroid infections. It is also possible that the route of infection may 
play a role in antiviral signaling induction in this model. CVB infects polarized cells through its 
receptor that is localized in the tight junction spaces (148, 239, 244), but the E11 receptor remains 
elusive, and therefore it is not known if the complex topography and 3-D structures of enteroids 
affects the ability of different enteroviruses to enter and infect cells. Additional studies will be 
required to resolve these remaining mechanistic questions.  As there are currently only very limited 
animal models for studying enterovirus pathogenesis, the multicellular complexity produced in the 
enteroid model will provide further insights into infection in the small intestine. 
4.3 CONCLUDING REMARKS 
In conclusion, the use of new cell culturing technologies to study epithelial barriers allows for the 
development of more relevant models of enterovirus infection at a site that it is crucially important 
but currently poorly understood. The development of proper polarized and differentiated models 
is important, as our lab has previously shown that some aspects of enterovirus infection of 
polarized cells such as entry, cell death signaling, and release, differ greatly compared to non-
polarized cells.  
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The two culturing models described in the previous sections each have their own sets of 
strengths and weaknesses. We demonstrate that Caco-2 cells grown in the 3-D RWV model 
develop in a consistent manner from batch to batch, based on transcriptional and morphological 
profiling (Figures 3 and 4). CVB infection results were also very consistent across independently 
grown cultures. The use of immortalized cells can also be advantageous as, unlike primary cells 
with very limited lifespans, they can be easily genetically manipulated. Cell lines with gene 
knockouts or those that have been stably transduced in order to express a transgene can be grown 
in the RWV and compared to wildtype cells. 3-D cell culturing can also be advantageous from a 
practical standpoint. Although the full culturing duration is 21 days, 3-D vessels can be seeded at 
any time, allowing for easier experimental design and setup compared to enteroid cultures, which 
are reliant on the availability of donated tissue for every experiment.  
The enteroid model provides the benefit of the development of properly differentiated 
IECs. As we have seen, there are markers for enterocytes, enteroendocrine, goblet, Paneth, and 
stem cells. As these cultures are produced directly from primary cells, they do not have the pitfalls 
associated with immortalized lines, such as altered cell cycles, aneuploidy, or other chromosomal 
aberrations. Also unlike cell lines, each sample is genetically distinct. This can be beneficial as 
samples would represent the genetic diversity of individual humans, but it also complicates 
experimental design and may interfere with the repeatability and consistency of results, due to 
genetic factors that are not possible to control for.  
In the enteroid model, cells grow and differentiate in more natural time frames. The RWV 
model we use requires that cells be cultured for a period of 21 days (as depicted in Figure 2), and 
cells reach confluence on beads several days after initial seeding (not shown). However, intestinal 
epithelial growth is much more rapid in vivo. Enterocytes and other cells migrate towards the villus 
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tips, where they are extruded, resulting in the turnover of entire villi in approximately 2-6 days 
(83). Active growth of villi, including the turnover and extrusion of cells could be important for 
models studying viral pathogenesis. This is particularly true for enteroviruses, which gain entry to 
cells via the tight junction spaces. Following extrusion, there is a 20 minute period before gaps 
between cells are sealed (292-295), during which tight junctional proteins are exposed to the 
lumen, potentially negatively impacting barrier function (296). Cell shedding, and thus gap 
formation and increased permeability can be further exacerbated by high levels of 
lipopolysaccharide or TNF, and epithelial gap incidence is significantly higher in patients with 
irritable bowel syndrome (IBD) compared to healthy patients (297). Future enteroid studies could 
help determine if cell shedding under these and other conditions affects intestinal barrier function 
to enteroviruses. 
Compared to other models for enterovirus infection in humans, the enteroid system is ideal 
for studies on tropism. Caco-2 cells grown in the RWV demonstrate a shift towards absorptive and 
goblet cell-like phenotypes based on mucin detection by UEA-1 (Figure 2), and have highly 
upregulated genes related to intestinal processes present (Figure 4). However, it is unlikely that 
the same discrete sub-lineages develop that can be found in vivo, based on the fact that the primary 
marker for goblet cells, Muc-2, cannot be detected at significant levels by RNASeq. In the enteroid 
model, however, we have shown a wider variety of cell types as well as differential infectivity in 
sub-lineages. Further work could elucidate the signaling responses of individual sub-lineages, 
following infection of FACS-sorted cells. Such experiments could determine whether enterocytes 
or enteroendocrine cells, specifically, are responsible for the induction of IFN and NF-κB antiviral 
signaling in response to E11 infection. We show that MUC2+ cells are less susceptible to E11 
infection and therefore Paneth cells, which are a small MUC2+ subpopulation, are unlikely to be 
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viral reservoirs. However, it is possible that they contribute to antiviral signaling indirectly. It has 
been shown in a macaque model that simian immune deficiency virus (SIV) can activate the NF-
κB pathway in Paneth cells very early in infection. This occurs without direct infection of Paneth 
cells, but instead by destroying neighboring epithelial cells (126). As we have shown by RNASeq 
and immunofluorescence, our model displays cellular markers for Paneth cells. As our cultures 
produce NF-κB signaling in response to E11, it may be worthwhile to investigate if Paneth cells 
play a pro-inflammatory role in our model. Transcriptional profiling of lineages that are sensitive 
or resistant to E11 infection could provide further insight into the mechanisms of viral replication 
in these cells, as well as reveal entry factors or the E11 receptor, which is currently unknown.  
In addition to epithelial subpopulations, it would also be interesting to study enterovirus 
infection in co-cultures of enteroids or 3-D grown cell lines with other biologically relevant cell 
types including immune and mesenchymal cells. Others have described co-cultures with 
macrophages to assess their effect on inflammatory innate signaling in the epithelium (298), and 
Raji B cells for their role in M cell differentiation. The mesenchyme also plays an important role 
in the development of the small intestinal in terms of epithelial differentiation and influencing the 
structure of the organ itself. Myofibroblasts and epithelial cell signaling crosstalk results in 
signaling cascades in both tissues. Others have described a murine enteroid co-culture model with 
myofibroblasts (225). Using similar co-culturing experiments, we would be able to determine if 
myofibroblasts affect differentiation or the susceptibility to infection of the enteroids in our model. 
Co-cultures or co-infections could also be established with bacteria, to determine what effect 
pathogenic and commensal microbes have on enterovirus infection. The presence of properly 
differentiated goblet and Paneth cells may create an environment that is more physiologically 
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relevant for bacterial adherence and invasion, due to the presence of a glycocalyx and proper brush 
border. 
 The only previously published studies on enterovirus tropism in specific intestinal sub-
lineages showed that PV is able to overcome the intestinal barrier by using M cells as a portal 
(114). However, direct infection of M cells by PV has not, to date, been shown. Instead, M cells 
uptake PV by transcytosis, a process normally used to sample antigen from the intestinal lumen 
and deliver it to local antigen presenting cells and lymphocytes (299). PV was reported to use M 
cell transcytosis in order to be transported from apical to basolateral epithelial surface (115). It is 
not yet known if this is the primary route by which PV bypasses the epithelium, nor is it known if 
other enteroviruses undergo M cell mediated transcytosis. We observed M cell specific markers 
SPIB and GP2 in our enteroid cell cultures (Figure 10) and expression of SPIB decreased following 
treatment with Notch inhibitor DBZ (Figure 13), consistent with the shift to an enrichment in 
absorptive cell lineage. We did not, however, successfully visualize M cells via microscopy in 
either 3-D or enteroid cultures, perhaps due to the relatively low abundance of M cells.  
In recent years, techniques have been developed to increase the ratio of M cells to 
enterocytes in vitro. This was initially accomplished by co-culturing Raji B cells with Caco-2, 
simulating a Peyer’s Patch like environment and causing the differentiation of “M cell like cells” 
(300-302). It was later discovered in mice that B cells help control M cell differentiation by 
secreting receptor activating NF-κB ligand (RANKL) and that this ligand is required for M cell 
uptake of luminal antigen (102). This technique has recently been utilized in an enteroid model, 
resulting in a significant increase in the abundance of functional M cells (230). Others have shown 
that it is possible to grow murine enteroids in sheets, rather than spherical structures, by plating on 
collagen coated plastic wells (225) or on transwell filters with fibronectin (224). Our lab has 
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recently determined that collagen treated transwell inserts are sufficient for growing human 
enteroid cultures into differentiated monolayer sheets (data not published). In combination, these 
techniques could be used to help study the process of transcytosis of PV and other enteroviruses. 
Although the spheroid nature of enteroids grown on Matrigel may be ideal for allowing the 
unrestricted growth of villi and crypts, it does complicate the general topography and structure, 
potentially abrogating viral access to apical surfaces. The use of trans-well plates would also allow 
for infection studies where virus delivery can be completely restricted to the apical or basolateral 
epithelial surfaces, which might be ideal for viral entry studies. 
Many aspects of the interactions between enteroviruses and the human intestinal epithelium 
remain unknown. Standard cell culture models consisting of cell lines grown on plastic in 
monolayers fail to recapitulate the development and differentiation of epithelial tissue that, in vivo, 
results in complex tissue containing villi and crypts comprised of a variety of cell lineages, each 
with specialized functions. Here, we have described two advanced cell culturing techniques for the 
purpose of modeling enterovirus infection in the small intestine. Further use and development of 
these strategies will advance our understanding of the early stages of enterovirus pathogenesis at 
the viral primary site of infection. 
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APPENDIX A 
SUPPLEMENTARY TABLES AND FIGURES 
Target Forward (5'-3') Reverse (5'-3') 
Actin ACTGGGACGACATGGAGAAAAA GCCACACGCAGCTC 
CDX1 GGAGAAGGAGTTTCATTACAG TGCTGTTTCTTCTTGTTCAC 
CVB3 ACGAATCCCAGTGTGTTTTGG TGCTCAAAAACGGTATGGACAT 
CXCL1 ATGCTGAACAGTGACAAATC TCTTCTGTTCCTATAAGGGC 
CXCL10 AAAGCAGTTAGCAAGGAAAG TCATTGGTCACCTTTTAGTG 
CXCL11 CTACAGTTGTTCAAGGCTTC CACTTTCACTGCTTTTAC 
Defa6 TCAAGTCTTAGAGCTTTGGG GTTAATACCCATGACAGTGC 
Echo11 CGCTATGGCTACGGGTAAAT GCAGTCCAACATCCCAGATAA 
EV71 GAGAGTTCTATAGGGGACAGT AGCTGTGCTATGTGAATTAGGAA 
HERC5 CAGAAAGTTGAATTTGTCGC CTGAGTCACTCTATACCCAAC 
Muc17 CAATGGAACTGACTGTGAC CCCGGAATACACAATATTCATC 
Muc2 GATTCGAAGTGAAGAGCAAG CACTTGGAGGAATAAACTGG 
NAALADL1 ACTACGAGTATTTTGGGGAC CAAAGTTCCGTTGAGGTTAC 
Reg3a TACTCATCGTCTGGATTGG ATCTTTCCACCTCAGAAATG 
 
Table 1. Primer sequences used in these studies 
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Supplemental Figure 1. (A) Unique gene reads and Reads Per Kilobase of transcript per Million mapped reads 
(RPKM) values from 2-D and 3-D Caco-2 cultures for CAR (CXADR), DAF (CD55), and PVR. (B), Heat map of 
log2 transformed RPKM values from 2-D and 3-D Caco-2 cultures. The color intensity in indicates the level of gene 
expression (yellow for high expression and blue for low expression), and grey indicates that no RNASeq reads were 
detected for that transcript in that sample.  
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Supplemental Figure 2. Supernatants of 2-D or 3-D Caco-2 cultures infected with CVB, or CVB virus stock, were 
incubated with a control antibody or anti-CVB neutralizing antibody (clone 280-5F-4E-5E, Millipore) at a 1:600 
dilution for 1hr and then added to HeLa cells for 6hrs.  Infection was quantified by RT-qPCR and is shown as a percent 
from 2-D supernatant with control antibody controls.  
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Supplemental Figure 3. (A) Immunofluorescence microscopy for vRNA (green) and CK19 (red) in enteroids infected 
with CVB for 24 hours. (B) ELISA for HMGB1, a marker for cell death, released by enteroid cultures infected for 24 
hours with CVB, EV71, or E11 relative to mock-infected enteroids **p<0.01.  
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Supplemental Figure 4. (A) Heatmap (based on log(RPKM) values in Figure 11A) of differentially expressed genes 
in enteroid samples infected with CVB compared to matched mock-infected controls. (B) Heatmap of differentially 
expressed genes in E11-infected enteroids compared to mock controls.  
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Supplemental Figure 5. (A) Gene set enrichment plots based upon GSEA of transcripts altered by E11 infection of 
enteroids. (B) mRNA levels for various interferons and interferon-stimulated genes in two E11-
infected enteroid cultures, relative to mock infections. (C) CXCL10 mRNA levels, as determined by RT-qPCR, in 
enteroids following infection by CVB or E11 or in response to treatment with 20 μg poly I:C, normalized to mock-
infected controls.  
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Supplemental Figure 6. (A) Immunofluorescence microscopy for E11 vRNA (red) and MUC2 (green) in enteroids 
infected with E11 for 24hrs. White arrows denote lack of infection in MUC2-positive 
cells. (B) Immunofluorescent confocal image of an enteroid stained for MUC2 (green) and actin (red). (C) Expression 
of markers of enterocytes (CDX1), goblet (MUC2), and Paneth cells (Reg3a and DefA6) in enteroids treated 
with DBZ or DMSO control, as determined by RT-qPCR. (D) Expression of Reg3A as assessed by RT-qPCR in 
enteroids or Caco-2 cells treated with DMSO control or DBZ. (E) Heatmap (based on log(RPKM) values) of 
transcripts uniquely induced by E11 infection in DBZ-treated enteroids. Data in (C-D) are shown as mean ± standard 
deviation and are normalized to DMSO-treated controls.  
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Supplemental Figure 7. (A) Heatmap (based upon log(RPKM values) of known enterovirus receptors in Caco-2 cells 
or enteroids as determined by RNASeq. (B) RT-qPCR for PV vRNA from Caco-2 cells or enteroids infected for 24hrs. 
Data are shown as mean ± standard deviation ΔCQ relative to actin.   
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APPENDIX B 
LIST OF ABBREVIATIONS 
ALB - albumin 
Atoh1 – atonal homolog 1 
AQP10 – aquaporin 10 
AWOL - autophagosome-mediated exit without lysis 
B3GNT – Beta-1,3-N-acetylglucosaminyltransferase 
Best4 - bestrophin 
BMP – bone morphogenic protein 
BNIP3L - BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like 
CAR – coxsackievirus and adenovirus receptor 
CBC – crypt base columnar stem cells 
cDNA – complementary DNA 
CDX - caudal Type Homeobox 1 
CHGA – chromogranin  
CNS – central nervous system 
CPE – cytopathic effect 
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CVA – coxsackievirus A 
CVB – coxsackievirus B 
CXCL - C-X-C motif ligand 
DAF – decay accelerating factor (CD55) 
DAMP – damage associated molecular pattern 
DAPI – 4’,6’-diamidino-2-phenylindole 
DBZ – dibenzazepine  
DCLK1 - doublecortin-like kinase 1  
DefA – alpha defensin 
DIC – differential interference contrast 
DKK1 – dickkopf WNT Signaling Pathway Inhibitor 
Dll1-4 – delta-like 1-4 
DMEM – Dulbecco’s modified eagle’s medium 
DMSO – dimethyl sulfoxide 
dsRNA – double stranded RNA 
E11 – echovirus 11 (ECHO = enteric cytopathic human orphan virus) 
ECM – extracellular matrix 
EDN1 – endothelin 1 
EGF – epidermal growth factor 
EGR1 – early growth response 1 
ELISA – enzyme-linked immunosorbent assay 
EV – enterovirus 
FAK – focal adhesion kinase 
 111 
FITC – fluorescein isothiocyanate 
FPKM – fragments per kilobase of transcript per million mapped reads  
GALT – gut-associated lymphoid tissue 
Gfi1 – growth factor independent 1 
GI – gastrointestinal 
GLUT5 – glucose transporter 5 
GnRH2 – gonadotropin releasing hormone 2 
GP2 – glycoprotein 2 
GPI – glycosylphosphatidylinositol 
HERC5 – HECT and RLD domain containing E3 ubiquitin protein ligase 5 
HES1 – hairy and enhancer of split 1 
HMGB1 – high-mobility group protein B1 
IEC – intestinal epithelial cell 
IFN – interferon  
IFNAR – interferon α/β receptor 
IL - interleukin 
IP – intraperitoneal  
IRES – internal ribosome entry site 
ISC – intestinal stem cell 
KLF4 - kruppel-like factor 4 
KRT – cytokeratin  
LDH – lactose dehydrogenase  
Lgr5 - leucine-rich repeat-containing G-protein coupled receptor 5 
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M cell – microfold cell 
MAVS – mitochondrial antiviral signaling protein 
MDA5 – melanoma differentiation-associated protein 5 
MEM – minimal essential medium 
MOI – multiplicity of infection 
MUC – mucin 
NAALADL1 – N-acetylated alpha-linked acidic dipeptidase like 1 
Neurog3 – neurogenin 3 
NF-κB – nuclear factor kappa light chain enhancer of B cells 
NGFR – nerve growth factor receptor 
NICD – notch intracellular domain 
NICU – neonatal intensive care unit 
NR – neutral red 
OLFM4 – olfactomedin 4 
Orm2 – orosomucoid 2 
PAMP – pathogen associated molecular pattern 
PCR – polymerase chain reaction 
PDGFRA – platelet-derived growth factor receptor alpha  
PFU – plaque forming unit 
p.i. – post infection 
Poly(I:C) – polyinosinic:polycytidylic acid 
PRR – pattern recognition receptor 
PV - poliovirus 
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PVR – poliovirus receptor 
qPCR – quantitative PCR 
RANK – receptor of nuclear factor kappa-B 
Reg3a – regenerating islet-derived protein III-alpha 
RIG-I – retinoic acid inducible gene I 
RIP3 – receptor interacting protein kinase 3 
RNASeq – whole transcriptome RNA sequencing 
RPKM - reads per kilobase of transcript per million mapped reads 
RT – reverse transcription 
RWV – rotating wall vessel 
SEM – scanning electron microscopy 
Sox9 – SRY-box 9 
SPIB – spleen focus-forming virus proviral integration oncogene B 
ssRNA – single stranded RNA 
STLV – slow turning lateral vessel 
TA – transit amplifying cells 
TBX2 – t-box 2 
TEM – transmission electron microscopy 
Tert – telomerase reverse transcriptase 
TJ – tight junction 
TLR – toll-like receptor 
TNFα – tumor necrosis factor α 
TRIF - Toll/IL-1 receptor domain containing adapter inducing IFNβ 
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UEA-1 – Ulex europaeus agglutinin 
VLA-2 – very late antigen 2 
VP1 – viral protein 1 
vRNA – viral RNA 
YIPF7 – Yip domain family member 7 
ZO-1 – zonula occludens  
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